Use: Labeled indications
- Cefixime is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections
- Otitis Media
- Pharyngitis and Tonsillitis
- Acute Exacerbations of Chronic Bronchitis
- Uncomplicated Gonorrhea (cervical/urethral)
- Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefixime and other antibacterial drugs, cefixime for oral suspension and…
Full indications and usage US FDA label
1 INDICATIONS AND USAGE Cefixime is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections (1.1) Otitis Media (1.2) Pharyngitis and Tonsillitis (1.3) Acute Exacerbations of Chronic Bronchitis (1.4) Uncomplicated Gonorrhea (cervical/urethral) (1.5) Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefixime and other antibacterial drugs, cefixime for oral suspension and cefixime capsules should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. (1.6) 1.1 Uncomplicated Urinary Tract Infections Cefixime for oral suspension and cefixime capsule is indicated in the treatment of adults and pediatric patients six months of age or older with uncomplicated urinary tract infections caused by susceptible isolates of Escherichia coli and Proteus mirabilis. 1.2 Otitis Media Cefixime for oral suspension and cefixime capsule is indicated in the treatment of adults and pediatric patients six months of age or older with otitis media caused by susceptible isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes.
(Efficacy for Streptococcus pyogenes in this organ system was studied in fewer than 10 infections.) Note: For patients with otitis media caused by Streptococcus pneumoniae, overall response was approximately 10% lower for cefixime than for the comparator [see Clinical Studies (14)]. 1.3 Pharyngitis and Tonsillitis Cefixime for oral suspension and cefixime capsule is indicated in the treatment of adults and pediatric patients six months of age or older with pharyngitis and tonsillitis caused by susceptible isolates of Streptococcus pyogenes. (Note: Penicillin is the usual drug of choice in the treatment of Streptococcus pyogenes infections.
Cefixime for oral suspension and cefixime capsule is generally effective in the eradication of Streptococcus pyogenes from the nasopharynx; however, data establishing the efficacy of cefixime for oral suspension and cefixime capsule in the subsequent prevention of rheumatic fever is not available.) 1.4 Acute Exacerbations of Chronic Bronchitis Cefixime for oral suspension and cefixime capsule is indicated in the treatment of adults and pediatric patients six months of age or older with acute exacerbations of chronic bronchitis caused by susceptible isolates of Streptococcus pneumoniae and Haemophilus influenzae. 1.5 Uncomplicated Gonorrhea (cervical/urethral) Cefixime for oral suspension and cefixime capsule is indicated in the treatment of adults and pediatric patients six months of age or older with uncomplicated gonorrhea (cervical/urethral) caused by susceptible isolates of Neisseria gonorrhoeae (penicillinase-and non-penicillinase-producing isolates). 1.6 Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug resistant bacteria and maintain the effectiveness of cefixime and other antibacterial drugs, cefixime for oral suspension and cefixime capsule should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy.
In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Contraindications
- Known allergy to cefixime or other cephalosporins
Contraindications (US label) US FDA label
4 CONTRAINDICATIONS Contraindicated in patients with known allergy to cefixime or other cephalosporins. (4) Cefixime is contraindicated in patients with known allergy to cefixime or other cephalosporins.
Dosing: Adult
- Adults: 400 mg once daily
- Uncomplicated cervical or urethral gonorrhea: 400 mg once
- S. pyogenes infections: At least 10 days
- CrCl below 60 mL/min: Reduced daily suspension volume (see kidney table)
- Adults: 400 mg daily (2.1)
- Pediatric patients (6 months and older): 8 mg/kg/day (2.2)
2.1 Adults
2.1 Adults The recommended dose of cefixime is 400 mg daily. This may be given as a 400 mg capsule daily. For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of 400 mg is recommended. The capsule may be administered without regard to food. In the treatment of infections due to Streptococcus pyogenes, a therapeutic dosage of cefixime should be administered for at least 10 days.
2.2 Pediatric Patients (6 months or older)
2.2 Pediatric Patients (6 months or older) The recommended dose is 8 mg/kg/day of the cefixime for suspension. This may be administered as a single daily dose or may be given in two divided doses, as 4 mg/kg every 12 hours. Note: A suggested dose has been determined for each pediatric weight range. Refer to Table 1. Ensure all orders that specify a dose in milliliters include a concentration, because cefixime for oral suspension is available in two different concentrations (100 mg/5 mL and 200 mg/5 mL).
Table1. Suggested doses for pediatric patients PEDIATRIC DOSAGE CHART Doses are suggested for each weight range and rounded for ease of administration Cefixime for oral s uspension 100 mg/5 mL 200 mg/5 mL Patient Weight (kg) Dose/Day (mg) Dose/Day (mL) Dose/Day (mL) 5 to 7.5 50 2.5 -- 7.6 to 10 80 4 2 10.1 to 12.5 100 5 2.5 12.6 to 20.5 150 7.5 4 20.6 to 28 200 10 5 28.1 to 33 250 12.5 6 33.1 to 40 300 15 7.5 40.1 to 45 350 17.5 9 45.1 or greater 400 20 10 Pediatric patients weighing more than 45 kg or older than 12 years should be treated with the recommended adult dose.
Otitis media should be treated with cefixime for oral suspension. Clinical trials of otitis media were conducted with the suspension, and the suspension results in higher peak blood levels than the tablet when administered at the same dose. Therefore, the cefixime tablet or cefixime capsule should not be substituted for the cefixime for oral suspension in the treatment of otitis media [see Clinical Pharmacology (12.3)].
In the treatment of infections due to Streptococcus pyogenes, a therapeutic dosage of cefixime should be administered for at least 10 days.
2.3 Renal Impairment
2.3 Renal Impairment Cefixime may be administered in the presence of impaired renal function. Normal dose and schedule may be employed in patients with creatinine clearances of 60 mL/min or greater. Refer to Table 2 for dose adjustments for adults with renal impairment. Neither hemodialysis nor peritoneal dialysis removes significant amounts of drug from the body.
Table2. Doses for Adults with Renal Impairment Renal Dysfunction Cefixime for Oral Suspension Creatinine Clearance (mL/min) 100 mg/5 mL 200 mg/5 mL Dose/Day (mL) Dose/Day (mL) 60 or greater Normal dose Normal dose 21 to 59 * OR renal hemodialysis * 13 6.5 20 or less OR continuous peritoneal dialysis 8.6 4.4 * The preferred concentrations of oral suspension to use are 200 mg/5 mL for patients with this renal dysfunction
2.4 Reconstitution Directions for Cefixime for Oral Suspension
2.4 Reconstitution Directions for Cefixime for Oral Suspension Table 3. Reconstitution Direction for Cefixime for Oral Suspension Strength Bottle Size Reconstitution Directions 200 mg/5 mL 75 mL To reconstitute, suspend with 51 mL water. Method: Tap the bottle several times to loosen powder contents prior to reconstitution.
Add approximately half the total amount of water for reconstitution and shake well. Add the remainder of water and shake well. 100 mg/5 mL and 200 mg/5 mL 50 mL To reconstitute, suspend with 34 mL water. Method: Tap the bottle several times to loosen powder contents prior to reconstitution. Add approximately half the total amount of water for reconstitution and shake well.
Add the remainder of water and shake well. After reconstitution, the suspension may be kept for 14 days either at room temperature, or under refrigeration, without significant loss of potency. Keep tightly closed. Shake well before using. Discard unused portion after 14 days.
Dosing: Altered kidney function
About 50% of absorbed cefixime is excreted unchanged in urine, and its half-life rises from 3 to 4 hours to about 11.5 hours in severe kidney impairment. The US label keeps the usual 400 mg daily dose at creatinine clearance (CrCl) 60 mL/min or more and gives reduced daily volumes of the oral suspension below that, with the same reduced doses on hemodialysis and CAPD. Dialysis does not remove significant amounts.
Kidney function measure: Label uses CrCl (mL/min); bands at 60 and 20. Reduced doses are given as suspension volumes.
Show full dosing details
- CrCl ≥60 mL/min
- CrCl 60 or more: usual dose (400 mg daily) (label).
- CrCl 30–59 mL/min
- CrCl 21–59: 13 mL/day of the 100 mg/5 mL suspension or 6.5 mL/day of the 200 mg/5 mL suspension (about 260 mg/day) (label Table 2; mg values calculated from the label volumes). Capsules and tablets (400 mg, and the 200 mg forms common in the Philippines) cannot give these doses; use the suspension (label footnote: the 200 mg/5 mL strength is preferred for CrCl 21–59 and hemodialysis).
- CrCl 15–29 mL/min
- CrCl 21–29: 13 mL/day of the 100 mg/5 mL suspension or 6.5 mL/day of the 200 mg/5 mL suspension (about 260 mg/day). CrCl 20 or less: 8.6 mL/day of the 100 mg/5 mL suspension or 4.4 mL/day of the 200 mg/5 mL suspension (about 172 to 176 mg/day) (label Table 2; mg values calculated). Capsules and tablets (400 mg, and the 200 mg forms common in the Philippines) cannot give these doses; use the suspension (label footnote: the 200 mg/5 mL strength is preferred for CrCl 21–59 and hemodialysis).
- CrCl <15 mL/min (not on dialysis)
- CrCl 20 or less: 8.6 mL/day of the 100 mg/5 mL suspension or 4.4 mL/day of the 200 mg/5 mL suspension (about 172 to 176 mg/day) (label Table 2; mg values calculated). Capsules and tablets (400 mg, and the 200 mg forms common in the Philippines) cannot give these doses; use the suspension (label footnote: the 200 mg/5 mL strength is preferred for CrCl 21–59 and hemodialysis).
- Hemodialysis (intermittent)
- Same as CrCl 21–59: 13 mL/day of the 100 mg/5 mL suspension or 6.5 mL/day of the 200 mg/5 mL suspension (about 260 mg/day) (label Table 2). Not removed significantly by hemodialysis; no supplement. Monitor carefully (label). Capsules and tablets (400 mg, and the 200 mg forms common in the Philippines) cannot give these doses; use the suspension (label footnote: the 200 mg/5 mL strength is preferred for CrCl 21–59 and hemodialysis).
- Peritoneal dialysis
- Continuous peritoneal dialysis: same as CrCl 20 or less: 8.6 mL/day of the 100 mg/5 mL suspension or 4.4 mL/day of the 200 mg/5 mL suspension (about 172 to 176 mg/day) (label Table 2). Not removed significantly by peritoneal dialysis. Capsules and tablets (400 mg, and the 200 mg forms common in the Philippines) cannot give these doses; use the suspension (label footnote: the 200 mg/5 mL strength is preferred for CrCl 21–59 and hemodialysis).
- CRRT
- Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
- Dialyzable? No: neither hemodialysis nor peritoneal dialysis removes significant amounts (label). About 65% protein bound.
- Monitoring CrCl for dose; patients on dialysis should be monitored carefully (label 5.3); prothrombin time with warfarin or in patients at risk; diarrhea (CDAD).
Children (kidney dosing)
Show full dosing details
- eGFR ≥60
- Usual pediatric dose (label).
- eGFR 30–59
- No pediatric kidney dosing in label (the reduced-dose table is for adults). Specialist input.
- eGFR 15–29
- No pediatric kidney dosing in label (the reduced-dose table is for adults). Specialist input.
- eGFR <15 (not on dialysis)
- No pediatric kidney dosing in label (the reduced-dose table is for adults). Specialist input.
- Hemodialysis (intermittent)
- No pediatric kidney dosing in label (the reduced-dose table is for adults). Specialist input.
- Peritoneal dialysis
- No pediatric kidney dosing in label (the reduced-dose table is for adults). Specialist input.
- CRRT
- No pediatric kidney dosing in label (the reduced-dose table is for adults). Specialist input.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
US label text: Renal impairment US FDA label
2.3 Renal Impairment Cefixime may be administered in the presence of impaired renal function. Normal dose and schedule may be employed in patients with creatinine clearances of 60 mL/min or greater. Refer to Table 2 for dose adjustments for adults with renal impairment. Neither hemodialysis nor peritoneal dialysis removes significant amounts of drug from the body.
Table2. Doses for Adults with Renal Impairment Renal Dysfunction Cefixime for Oral Suspension Creatinine Clearance (mL/min) 100 mg/5 mL 200 mg/5 mL Dose/Day (mL) Dose/Day (mL) 60 or greater Normal dose Normal dose 21 to 59 * OR renal hemodialysis * 13 6.5 20 or less OR continuous peritoneal dialysis 8.6 4.4 * The preferred concentrations of oral suspension to use are 200 mg/5 mL for patients with this renal dysfunction
8.6 Renal Impairment The dose of cefixime should be adjusted in patients with renal impairment as well as those undergoing continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD). Patients on dialysis should be monitored carefully [see Dosage and Administration (2.3)].
Patients with Renal Impairment: In subjects with moderate impairment of renal function (20 to 40 mL/min creatinine clearance), the average serum half-life of cefixime is prolonged to 6.4 hours. In severe renal impairment (5 to 20 mL/min creatinine clearance), the half-life increased to an average of 11.5 hours. The drug is not cleared significantly from the blood by hemodialysis or peritoneal dialysis. However, a study indicated that with doses of 400 mg of cefixime, patients undergoing hemodialysis have similar blood profiles as subjects with creatinine clearances of 21 to 60 mL/min.
Dosing: Pediatric
- Approved ages
- 6 months and older (label).
- Usual dose
- 8 mg/kg/day of the suspension, once daily or as 4 mg/kg every 12 hours (label).
- Maximum dose
- Children over 45 kg or older than 12 years: adult dose (label).
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedPediatric use (US label) US FDA label
8.4 Pediatric Use The safety and effectiveness of cefixime have been established in pediatric patients 6 months of age and older. Safety and effectiveness of cefixime in pediatric patients younger than 6 months of age have not been established. The incidence of gastrointestinal adverse reactions, including diarrhea and loose stools, in the pediatric patients receiving the cefixime for oral suspension, was comparable to the incidence seen in adult patients receiving tablets.
Dosing: Older adult
Geriatric use (US label) US FDA label
8.5 Geriatric Use Clinical studies did not include sufficient numbers of subjects aged 65 and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. A pharmacokinetic study in the elderly detected differences in pharmacokinetic parameters [see Clinical Pharmacology (12.3)]. These differences were small and do not indicate a need for dosage adjustment of cefixime in the elderly.
Administration
2.4 Reconstitution Directions for Cefixime for Oral Suspension Table 3. Reconstitution Direction for Cefixime for Oral Suspension Strength Bottle Size Reconstitution Directions 200 mg/5 mL 75 mL To reconstitute, suspend with 51 mL water . Method: Tap the bottle several times to loosen powder contents prior to reconstitution. Add approximately half the total amount of water for reconstitution and shake well. Add the remainder of water and shake well. 100 mg/5 mL and 200 mg/5 mL 50 mL To reconstitute, suspend with 34 mL water . Method: Tap the bottle several times to loosen powder contents prior to reconstitution. Add approximately half the total amount of water for reconstitution and shake well. Add the remainder of water and shake well. After reconstitution, the suspension may be kept for 14 days either at room temperature, or under refrigeration, without significant loss of potency. Keep tightly closed. Shake well before using. Discard unused portion after 14 days.
US FDA labelDosage forms
Philippines
- Film-coated tablet: 200 mg, 400 mg
- Granule for suspension: 20 mg per mL, 20 mg/mL, 100 mg/5 mL
- Capsule: 100 mg, 200 mg, 400 mg
- Powder for suspension: 20 mg/mL, 50 mg/5 mL, 100 mg, 100 mg/5 mL, 200 mg/5 mL
- Powder for oral suspension: 20 mg/mL, 100 mg, 100 mg/5 mL, 200 mg/5 mL
- Dispersible tablet: 100 mg, 200 mg, 400 mg
- ) powder for oral suspension: 100 mg/5 mL (20 mg/mL
- Orodispersible tablet: 400 mg
- Oral powder for suspension: 100 mg
- Chewable tablet: 100 mg, 400 mg
and 4 more forms; see the products table.
Registered products in the Philippines
388 products registered with the Food and Drug Administration (FDA) Philippines list Cefixime as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products388
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AccefiximeCefixime (as Trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE White Plastic Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Accesspoint International Trading Inc. | DRP-5926 | Oct 12, 2031 | |
Accefixime DSCefixime (as dihydrate) | 200 mg/5 mL Powder for Oral SuspensionHDPE White Plastic Bottle with Pilfer-Proof Cap x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Accesspoint International Trading Inc. | DRP-5931 | Jun 20, 2028 | |
AcecefCefixime (as trihydrate) | 100 mg/ 5 mL (20 mg/mL) Powder for Oral SuspensionHDPE plastic bottle x 60 mL (Box of 1’s) | Rx | Globela Laboratories Private LimitedIndia | Genace Pharma DistributorImporter: AMB HK Enterprises Inc. | DRP-12591-05 | Sep 19, 2027 | |
AcecefCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1’s); HDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Genace Pharma DistributorImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-09 | Sep 17, 2029 | |
AcecefCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Sakar Healthcare Pvt. Ltd.India | Genace Pharma DistributorImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-20 | Nov 27, 2028 | |
AcecefCefixime (as trihydrate) | 20 mg / mL Powder for Oral Suspension (Oral Drops)HDPE plastic bottle with medicine dropper x 10 mL and 30 mL (Box of 1 's) | Rx | Globela Laboratories Private LimitedIndia | Genace Pharma DistributorImporter: AMB HK Enterprises Inc. | DRP-12592-05 | Sep 19, 2027 | |
ActimaxCefixime (as Trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10’s Box of 50’s | Rx | Zim Laboratories LimitedIndia | Triple Tact Import and Export Corp.Importer: Suhitas Pharmaceuticals Inc.Trader: PSA International (Export Division of PSA Chemicals and Pharmaceuticals Pvt. Ltd.) | DRP-1717 | Nov 20, 2029 | |
AmkofixCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | AMK Pharma International TradingImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-04 | Nov 27, 2028 | |
AmkoxiCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1’s); HDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-23 | Sep 17, 2029 | |
AppeximeCefixime (As Trihydrate) | 100 mg/5 mL Granules For SuspensionBoston Round Amber Bottle x 30 mL and 60 mL | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Appex MD's Pharmaceutical Inc. | DRP-5052-07 | Aug 18, 2027 | |
ArgifixCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Sanreich Healthcare, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-05 | Sep 17, 2029 | |
BacticefCefixime (as trihydrate) | 100 mg Oral Powder for Suspension (Chocolate Flavor)60 mL-capacity White HDPE bottle x 60 mL with white HDPE cap and measuring cup (Box of 1’s) | Rx | East African (India) OverseasIndia | Euroasia Pharmaceuticals, IncImporter: Ambica International Corporation | DRP-17310-01 | Nov 14, 2030 | |
BacticefCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare LimitedIndia | Euroasia Pharmaceuticals, Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-14 | Nov 27, 2028 | |
BacticefCefixime (as trihydrate) | 200 mg capsuleAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Sakar Healthcare Pvt. LtdIndia | EuroAsia Pharmaceuticals, Inc. | DRP-6904 | Sep 6, 2031 | |
BactiximeCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Primedrug Marketing CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-09 | Nov 27, 2028 | |
BactroCef DSCefixime (as trihydrate) | 200 mg/5 mL Powder for Oral SuspensionHDPE White Plastic Bottle with Pilfer-Proof Cap x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | AFEA-MED Pharmaceutical Products TradingImporter: Accesspoint International Trading, Inc. | DRP-5931-05 | Jun 20, 2028 | |
BactroximeCefixime (as Trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE White Plastic Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | NJT EnterprisesImporter: Accesspoint International Trading Inc. | DRP-5926-01 | Oct 12, 2031 | |
Bactroxime DSCefixime (as trihydrate) | 200 mg/ 5 mL Powder for Oral SuspensionHDPE white plastic bottle with pilfer proof cap x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | NJT EnterprisesImporter: Accesspoint International Trading Inc. | DRP-5931-01 | Jun 20, 2028 | |
Bacxide 3Cefixime Trihydrate | 200 mg Dispersible TabletAlu/Alu Blister Pack x 10 Tablets per Box (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Pharma King DistributorImporter: Pharmakon Biotec Inc. | DRP-4749-13 | Jul 10, 2028 | |
Beraxime-DSCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Prodrom Nutritionals, IncorporatedImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-12 | Sep 17, 2029 | |
BeximeCefixime (As Trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle X 30mL and 60 mL with Polypropylene Measuring Cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Pharmahealth Enterprises | DRP-5052-30 | Aug 18, 2027 | |
BhecximeCefixime (as trihydrate) | 100 mg / 5 mL Powder for Oral SuspensionHDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | Baroque Pharmaceuticals Pvt. Ltd.India | Prebiotech Health Products Phils.Importer: Hexagon Pharmaceuticals | DRP-14549 | Feb 10, 2030 | |
BioximeCefixime (as trihydrate) | 20 mg/mL Powder for Oral Suspension (Oral Drops)HDPE plastic bottle with medicine dropper x 10 mL and 30 mL (Box of 1's) | Rx | Globela Laboratories Private LimitedIndia | Bio Erixx Pharma DistributionImporter: AMB HK ENTERPRISES INC. | DRP-12592-04 | Sep 19, 2027 | |
CedixCefixime Trihydrate | 200 mg Dispersible TabletAlu/Alu Blister Pack x 10 Tablets per Box x 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Vispomed CorporationImporter: Pharmakon Biotec Inc. | DRP-4749-03 | Jul 10, 2028 | |
Ceenax 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | East African (India) OverseasIndia | Medvybe Pharmaceutical TradingImporter: Divjot Enterprises Corp. | DRP-17921-01 | Feb 25, 2031 | |
Ceenax 400Cefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | East African (India) OverseasIndia | Medvybe Pharmaceutical TradingImporter: Divjot Enterprises Corp. | DRP-17909-01 | Jan 19, 2031 | |
CefegoldCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 30 mL and 60 mL with polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Gold Life Distribution Phils. Inc. | DRP-5052-32 | Aug 18, 2027 | |
CefegoldCefixime | 20mg/mL Granules For Suspension (Oral Drops)10mL net content bin 15mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Gold Life Distribution Phils. Inc. | DRP-5683-28 | Feb 20, 2029 | |
CefekiximeCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL Box of 1's | Rx | Sakar Healthcare LimitedIndia | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-17 | Nov 27, 2028 | |
CefetechCefixime | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s in a monocarton (Box of 100’s) | Rx | Sance Laboratories Pvt. Ltd.India | Greencore Pharma Inc. | DRP-18399 | Jun 30, 2031 | |
CeffixCefixime (as Trihydrate) | 400mg CapsuleAlu/Alu Blister Pack x 5's (Box of 5's) | Rx | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Stangen Pharmaceuticals Philippines Inc. | DR-XY43653 | Aug 26, 2027 | |
Cefi-SkyCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL ()Box of 1's | Rx | Sakar Healthcare LimitedIndia | Skymed Pharma DistributorImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-13 | Nov 27, 2028 | |
Cefichew 400Cefixime (as trihydrate) | 400 mg Chewable TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Maxim Pharmaceuticals, Pvt. Ltd.India | SRS Life Sciences Inc. | DRP-5109 | Jul 17, 2028 | |
CeficureCefixime Trihydrate | 200 mg Dispersible TabletAlu/Alu Blister Pack x 10 Tablets per Box (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Altor Pharmaceutical Product DistributionImporter: Pharmakon Biotec Inc. | DRP-4749-11 | Jul 10, 2028 | |
CeficzoneCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 1 Blister Pack x 10 tablets) | Rx | Innova Captab Ltd. (Unit II)India | Detoxicare Phils., Inc.Importer: Ambica International Corporation | DRP-14009-01 | Jun 5, 2028 | |
CefidenCefixime (as trihydrate) | 100 mg /5 mL (20 mg/mL) Powder for Oral SuspensionHDPE plastic bottle x 30 mL and 60 mL (Box of 1's) | Rx | Globela Laboratories Private LimitedIndia | Cyden Medicale Trading Inc.Importer: AMB HK Enteprises Inc. | DRP-12591-01 | Sep 19, 2027 | |
CefidenCefixime (as trihydrate) | 20 mg/mL Powder for Oral Suspension (Oral Drops)HDPE plastic bottle with medicine dropper x 10 mL and 30 mL (Box of 1's) | Rx | Globela Laboratories Private LimitedIndia | Cyden Medicale Trading Inc.Importer: AMB HK Enteprises Inc. | DRP-12592-01 | Sep 19, 2027 | |
CefidenCefixime (as trihydrate) | 200 mg Dispersible Tablet (Trusil Strawberry Flavor)Alu/Alu Blister Pack x 10's (Box of 10's) | Rx | Innova Captab Ltd.India | Cyden Medicale Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-13665-04 | Mar 23, 2028 | |
Cefifer-100Cefixime (as Trihydrate) | 100 mg/ 5 mL Granules for Suspension (Strawberry Flavor)HDPE Bottle x 60 mL (Box of 1's) | Rx | Pharmevo (Pvt.) Ltd.Pakistan | Ferjan Healthlink Philippines, Inc.Importer: Accesspoint International Trading Inc. | DRP-4029-10 | Dec 12, 2026 | |
Cefiflob-400Cefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Globela Laboratories Pvt. Ltd.India | AMB HK Enterprises, Inc.Trader: N/A | DRP-14681 | Nov 22, 2028 | |
CefigenCefixime (as trihydrate) | 100 mg/5mL Granules for SuspensionBoston Round Amber Bottle x 30ml and 60ml (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Quad-Gen Pharmaceuticals | DRP-5052-18 | Aug 18, 2027 | |
CefilimCefixime (as trihydrate) | 100 mg / 5ml Powder for SuspensionHDPE Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Saga Lifesciences LimitedIndia | Hexagon Pharmaceuticals | DRP-7321 | Oct 8, 2029 | |
CefimCefixime (as trihydrate) | 20 mg/mL Granules for Suspension (Oral Drops)15 mL in 30 mL Amber Glass Bottle with Dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-10383 | Dec 2, 2029 | |
CefimaxCefixime (as Trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Basic Pharmaceutical Corporation | DRP-5052-10 | Aug 18, 2027 | |
CefimaxCefixime (as trihydrate) | 200 mg CapsuleAlu Foil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Basic Pharmaceutical Corp. | DR-XY44302 | Apr 13, 2030 | |
CefinavCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's in a Box of 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | JNC Pharmaceuticals CorporationImporter: Pharmakon Biotec, Inc. | DRP-5121-16 | Oct 14, 2028 | |
Cefinox 400Cefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 10's) | Rx | Innova Captab Pvt. Ltd.India | Pharmakon Biotec Inc. | DRP-13949 | May 24, 2028 | |
Cefinox-DT 200Cefixime (as trihydrate) | 200 mg Dispersible Tablet (Trusil Strawberry Flavor)Alu/Alu Blister Pack x 10's (Box of 10's) | Rx | Innova Captab Ltd.India | Pharmakon Biotec, Inc. | DRP-13665 | Mar 23, 2028 | |
CefiProCefixime (as Trihydrate) | 100 mg / 5mL Powder for SuspensionHDPE White Plastic Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Prebiotech Advanced Pharma Inc.Importer: Accesspoint International Trading Inc. | DRP-5926-11 | Oct 12, 2031 | |
Cefipro 200Cefixime (as trihydrate) | 200mg Film-Coated TabletAlu/Foil Strip Pack x 10's (Box of 20's) | Rx | Celogen Pharma Pvt. Ltd.India | Prebiotech Advanced Pharma Inc.Importer: Pharmastar Int'l Trading Corp. | DRP-8648-02 | Sep 26, 2029 | |
CefironCefixime (As Trihydrate) | 200 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Philrx Pharma Inc. | DRP-18902 | Sep 29, 2031 | |
CefirylCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine Dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | CROWN PHARMACEUTICAL DISTRIBUTION | DRP-5683-12 | Feb 20, 2029 | |
Cefisal-200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s, 30's, and 100’s | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India | GX International, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-2654 | Dec 20, 2028 | |
CefitomeCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionHDPE bottle with measuring cup x 60 mL and 100 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-16268 | Jan 16, 2030 | |
CefitomeCefixime (as trihydrate) | 200 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Indchemie Health Specialties Private LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-14120 | Jun 23, 2028 | |
CefitomeCefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Indchemie Health Specialities Private LimitedIndia | Suhitas Pharmaceuticals, Inc. | DRP-14859 | Jan 24, 2029 | |
CefitreneCefixime (As Trihydrate) | 100 mg/5 mL Granules For SuspensionBoston Round Amber Glass Bottle x 30 mL and 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Aisec Farma Corporation | DRP-5052-04 | Aug 18, 2027 | |
Cefitrene 100Cefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Aisec Farma CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-19 | Sep 17, 2029 | |
Cefitrene 100Cefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Ltd.India | AISEC Farma CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-24 | Nov 27, 2028 | |
CefitrineCefixime | 20 mg/mL Granules For Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | AISEC FARMA CORPORATION | DRP-5683-03 | Feb 20, 2029 | |
Cefivix-400Cefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 1 blister pack x 10 tablets) | Rx | Innova Captab Ltd.India | Teramedix Pharma Trading Inc. | DRP-13987 | Jun 1, 2028 | |
CefiwellCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 30 mL and 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Castellano Drug | DRP-5052-25 | Aug 18, 2027 | |
CEFIWELLCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine Dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | CASTELLANO DRUG | DRP-5683-07 | Feb 20, 2029 | |
CefixedCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionBoston Round Amber Bottle x 30 mL (Box of 1’s); Boston Round Amber Bottle x 60 mL (Box of 1’s); Boston Round Amber Bottle x 70 mL (Box of 1’s) | Rx | Sunlovis Pharmaceuticals LLP.India | 777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4185-03 | Jan 28, 2028 | |
CefixedCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | SAPPHIRE LIFESCIENCES PVT. LTDIndia | 777 Red Pharma IncImporter: Nelpa Lifesciences, Inc. | DRP-4185-01 | Jan 28, 2028 | |
Cefixi-BrillCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 30 mL and 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Rcbrilliant Pharma Corp | DRP-5052-35 | Aug 18, 2027 | |
Cefixi-BrillCefixime | 20 mg / mL Granules for Suspension (Oral Drops)10mL net content in 15mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | RCBrilliant Pharma Corp. | DRP-5683-31 | Feb 20, 2029 | |
CefixneedCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu-Alu blister pack x 10's (Box of 10's) | Rx | Zim Laboratories Ltd.India | Genace Pharma DistributorImporter: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-05 | Oct 24, 2027 | |
Cefixsaph-100Cefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | SAPPHIRE LIFESCIENCES PVT. LTDIndia | NELPA LIFESCIENCES, INC. | DRP-4185 | Jan 28, 2028 | |
CefixsaveCefixime (as Trihydrate) | 100 mg / 5 mL Powder for SuspensionHDPE White Plastic Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Savelink Pharma And Trading Co.Importer: Accesspoint International Trading Inc. | DRP-5926-09 | Oct 12, 2031 | |
CefixstanCefixime (As Trihydrate) | 100 mg/5 mL Granules For SuspensionBoston Round Amber Bottle X 60 mL With Polypropylene Measuring Cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Westfield Pharmaceuticals, Inc. | DRP-5052-29 | Aug 18, 2027 | |
CefmetabCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Brawn Laboratories LimitedIndia | Ambica International Corporation | DRP-4709 | Sep 13, 2028 | |
Cefolin DSCefixime (as trihydrate) | 50 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4962 | Nov 27, 2028 | |
Cefolin Plus DSCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Applied Pharmaceutical Distribution Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961 | Nov 27, 2028 | |
CefphilCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Phil Asia Pharma Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-08 | Nov 27, 2028 | |
CefthixCefixime (as trihydrate) | 100 mg CapsuleAlu/Alu PVC Blister Pack x 10's (Box of 100's) | Rx | Medico Remedies LimitedIndia | Medethix, Inc. | DRP-14422 | Sep 6, 2028 | |
CefthixCefixime (as trihydrate) | 200 mg CapsuleAlu/Alu PVC Blister Pack x 10's (Box of 100's) | Rx | Medico Remedies LimitedIndia | Medethix, Inc. | DRP-16411 | Mar 10, 2030 | |
CefthixCefixime (as trihydrate) | 400 mg CapsuleAlu/Alu PVC Blister Pack x 10's (Box of 100's) | Rx | Medico Remedies LimitedIndia | Medethix, Inc. | DRP-14426 | Sep 4, 2028 | |
CeftriCefixime (As Trihydrate) | 100 mg/5 mL Granules For SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) with polypropylene measuring cup | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc. | DRP-5052-12 | Aug 18, 2027 | |
CeftriCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | ALTOMED PHARMACEUTICALS, INC. | DRP-5683-06 | Feb 20, 2029 | |
CeftrikidsCefixime | 20 mg / mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber bottle with medicine dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | NUTRAMEDICA INC. | DRP-5683-23 | Feb 20, 2029 | |
CeftrimedCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 30 mL and 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Metro Manila | Nutramedica Inc. | DRP-5052 | Aug 18, 2032 | |
CefulaxCefixime (as trihydrate) | 100 mg/5 mL Granules for Suspension.Boston Round Amber Bottle X 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Marti-Lian Pharma Link | DRP-5052-11 | Aug 18, 2027 | |
CefulaxCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | MARTI-LAIN PHARMA LINK | DRP-5683-05 | Feb 20, 2029 | |
Cefxihyd 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100's) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India | Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-2654-05 | Dec 20, 2028 | |
CefxitrixCefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 4's Box of 4's | Rx | XL Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-3859-02 | Jul 24, 2027 | |
CEFZINCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | STARPHARM, INC. | DRP-5683-17 | Feb 20, 2029 | |
Cefzin-SCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle X 60 mL Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc..Philippines | Starpharm, Inc. | DRP-5052-21 | Aug 18, 2027 | |
Cefzin-SCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's and 50's) | Rx | Zim Laboratories LimitedIndia | Starpharm, Inc.Importer: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-10 | Oct 24, 2027 | |
Cemop 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's | Rx | Zim Laboratories Ltd.India | Dynasty PharmaceuticalsImporter: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-04 | Oct 24, 2027 | |
Cenoxim 200Cefixime (as trihydrate) | 200 mg Film Coated TabletAlu/Alu blister pack x 10's (Box of 100's) | Rx | Innova Captab Ltd.India | Airlife International Trading Corporation | DRP-17821 | Mar 16, 2031 | |
Cenoxim 400Cefixime (as trihydrate) | 400 mg Film Coated TabletAlu/Alu blister Pack x 10's (Box of 100's) | Rx | Innova Captab Ltd.India | Airlife International Trading Corporation | DRP-17789 | Mar 11, 2031 | |
CEPRIMECefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with Medicine Dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | RL PHARMA ENTERPRISES INC. | DRP-5683-13 | Feb 20, 2029 | |
CerofectCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's in a Box of 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | NAB Trading Corp.Importer: Pharmakon Biotec, Inc. | DRP-5121-15 | Oct 14, 2028 | |
CeximCefixime (As Trihydrate) | 100mg/5mL Granules For SuspensionBoston Round Amber Bottle x 60ml | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Westfield Pharmaceuticals, Inc. | DRP-5052-14 | Aug 18, 2027 | |
CeximeCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1's); HDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Altomed Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-01 | Sep 17, 2029 | |
CFX-200Cefixime Trihydrate | 200 mg Dispersible TabletAlu/Alu Blister Pack x 10 Tablets per Box (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Alpha Farmaceutico Corp.Importer: Pharmakon Biotec Inc. | DRP-4749-08 | Jul 10, 2028 | |
ComfiximeCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1’s); HDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Pharmacom DistributionImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-13 | Sep 17, 2029 | |
CoreXimeCefixime (as trihydrate) | 100 mg/5 mL Powder for Suspension60 mL HDPE Bottle (Box of 1's) | Rx | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Greencore Pharma Inc.Importer: Accesspoint International Trading Inc. | DRP-13909-05 | Feb 15, 2037 | |
CureximeCefixime (as trihydrate) | 100 mg/ 5 mL (20 mg/mL) Powder for Oral SuspensionHDPE plastic bottle x 60 mL (Box of 1’s) | Rx | Globela Laboratories Pvt. Ltd.India | Curecare Pharmaceutical Products DistributionImporter: AMB HK Enterprises Inc. | DRP-12591-04 | Sep 19, 2027 | |
Dancef 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's) | Rx | Zim Laboratories Ltd.India | D & G PharmaImporter: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-07 | Oct 24, 2027 | |
Dancef-DSCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | D & G PharmaImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-03 | Nov 27, 2028 | |
Diaxime 200Cefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | Pharmalife DistributionImporter: Ambica International Corporation | DRP-4051-02 | Oct 16, 2027 | |
Dixime-200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack by 10's in a Box x 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Medhart Pharma Inc.Importer: Pharmakon Biotec Inc. | DRP-5121-05 | Oct 14, 2028 | |
Dixime-400Cefixime (as trihydrate) | 400 mg Orodispersible TabletAlu/Alu Blister Pack x 10's in Individual Box of 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-6669-01 | May 20, 2036 | |
DyruximCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Zim Laboratories Ltd.India | Dynasty PharmaceuticalsImporter: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-06 | Oct 24, 2027 | |
Dyruxim-100Cefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL Box of 1’s | Rx | Zim Laboratories LimitedIndia | Dynasty PharmaceuticalsImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-11 | Sep 17, 2029 | |
ElvofixCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Diafarm Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-06 | Sep 17, 2029 | |
EmacifCefixime (as trihydrate) | 100 mg/5 mL Powder for Suspension30 mL and 60 mL HDPE Bottle (Box of 1's) | Rx | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Accesspoint International Trading Inc. | DRP-13909 | Feb 15, 2037 | |
EmfiximeCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Manumed Pharmaceutical, Inc. | DRP-5052-34 | Aug 18, 2027 | |
EmfiximeCefixime (as trihydrate) | 20 mg/mL Granules for Suspension (Oral Drops)15 mL in 30 mL Amber Glass Bottle with Dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Manumed Pharmaceutical Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-10383-04 | Dec 2, 2029 | |
EriexefCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1’s); HDPE Bottle x 60 mL (Box of 1's) | Rx | Zim Laboratories LimitedIndia | Quad-Gen PharmaceuticalsImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-16 | Sep 17, 2029 | |
EriexefCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Quad-Gen PharmaceuticalsImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-21 | Nov 27, 2028 | |
EvofixCefixime (as Trihydrate) | 100 mg/ 5 mL Granules for Suspension | Rx | — | Importer: Accesspoint International Trading Inc. | DRP-4029 | Dec 12, 2026 | |
EzcefCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | Scott-Edil Advance Research Laboratories & Education Ltd.India | EON Pharmatek, Inc.Trader: I-Care Pharmaceuticals Pvt. Ltd. | DR-XY43673 | Dec 12, 2030 | |
EzcefCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x I0's (Box of 30's and 100's) | Rx | Scott-Edil Advance Research Laboratories & Education Ltd.India | EON PHARMATEK INC.Trader: I-Care Pharmaceuticals Pvt. Ltd. | DR-XY44013 | Dec 19, 2029 | |
FeximwinCefixime (as trihydrate) | 200 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 1 Blister pack x 10 tablets) | Rx | Innova Captab Ltd. (Unit II)India | Ambica International Corporation | DRP-14009 | Jun 5, 2028 | |
FeximwinCefixime (as trihydrate) | 400 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 1 Blister pack x 10 tablets) | Rx | Innova Captab Ltd. (Unit II)India | Ambica International Corporation.Importer: Ambica International Corporation | DRP-14010 | Jun 5, 2028 | |
FexitasCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s) | Rx | Sance Laboratories Pvt. Ltd.India | Littman Drug CorporationImporter: Suhitas Pharmaceuticals Inc. | DRP-4899 | Nov 20, 2031 | |
Fimabute-200Cefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10's Box of 10's and 100's | Rx | Brawn Laboratories LimitedIndia | Ambica International Corporation | DRP-4051 | Oct 16, 2027 | |
Fimabute-DTCefixime (as trihydrate) | 100 mg Dispersible TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | Ambica International Corporation | DRP-4048 | Oct 16, 2027 | |
Finaxiv-200Cefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Medico Remedies LimitedIndia | Helande Kidney Care Inc.Importer: Medethix, Inc. | DRP-14446-01 | Sep 6, 2028 | |
Finaxiv-400Cefixime (as trihydrate) | 400 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Medico Remedies LimitedIndia | Helande Kidney Care Inc.Importer: Medethix, Inc. | DRP-13935-01 | May 18, 2028 | |
Fix-ACefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionAmber Glass Bottle x 50 mL (Box of 1's); Amber Glass Bottle x 37.5 mL (Box of 1's) | Rx | The ACME Laboratories LimitedBangladesh | Euro Generics International Phils., Inc. | DRP-2403 | Mar 14, 2028 | |
FixalCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionAmber Glass Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Bosch Pharmaceuticals (Pvt.) Ltd.Pakistan | Jalmedbase Pharma Corp.Importer: Sahar International Trading Inc. | DRP-13567-02 | Aug 14, 2031 | |
FixbactCefixime | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | NGB Laboratories Pvt. Ltd.India | — | DRP-12216 | Jul 6, 2027 | |
FixbactCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack by 10's in a Box x 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Bell-Kenz Pharma Inc.Importer: Pharmakon Biotec Inc. | DRP-5121 | Oct 14, 2028 | |
FixbactCefixime (As Trihydrate) | 200mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Baroque Pharmaceuticals Pvt. LtdIndia | AMB HK Enterprises Inc. | DRP-18351 | Jun 18, 2031 | |
FixbactCefixime (as trihydrate) | 400 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | AMB HK Enterprises IncImporter: AMB HK Enterprises Inc. | DRP-18508 | Jul 27, 2031 | |
FixcefCefixime (as trihydrate) | 400 mg CapsuleAlu/Alu Blister Pack x 5's (Box of 10's) | Rx | Bosch Pharmaceuticals (Pvt.) Ltd.Pakistan | Sahar International Trading, Inc. | DRP-13575 | Dec 4, 2029 | |
FixcureCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Zim Laboratories Ltd.India | Phil Asia Pharma Inc.Importer: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-01 | Oct 24, 2027 | |
Fixef-200Cefixime (as trihydrate) | 200 mg CapsuleAlu Foil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Euro-Health Care Exponents, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-8070-04 | Apr 13, 2030 | |
Fixhil 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Swiss Pharma Pvt. Ltd.India | Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7356-05 | Feb 21, 2029 | |
Fixhil 400Cefixime (as trihydrate) | 400 mg Dispersible TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Swiss Pharma Pvt. Ltd.India | Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7357-04 | Feb 26, 2029 | |
FixiconCefixime (as trihydrate) | 400 mg Dispersible TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Swiss Pharma Pvt. Ltd.India | D'Conner PharmaImporter: Sanimed Pharmaceuticals Inc. | DRP-7357-05 | Feb 26, 2029 | |
FixidropsCefixime | 20mg/mL Granules for Suspension (Oral Drops)10mL net content in 15mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | TGP Pharma Inc. | DRP-5683-26 | Feb 20, 2029 | |
FixigenCefixime (as trihydrate) | 100 mg / 5 mL (20 mg / mL) Powder for Oral SuspensionHDPE plastic bottle x 30 mL and 60 mL (Box of 1's) | Rx | Globela Laboratories Private LimitedIndia | Quad-Gen PharmaceuticalsImporter: AMB HK Enterprises Inc. | DRP-12591-02 | Sep 19, 2027 | |
FiximeCefixime (as trihydrate) | 200 mg CapsuleAlu Foil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DR-XY44301 | Apr 13, 2030 | |
FixinCefixime Trihydrate | 200 mg Dispersible TabletAlu/Alu Blister Pack x 10 tablets per Box (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Curasave PharmaImporter: Pharmakon Biotec Inc. | DRP-4749-02 | Jul 10, 2028 | |
FixsilCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Pharmasilv TradingImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-01 | Nov 27, 2028 | |
Fixsil-200Cefixime (as trihydrate) | 200 mg Film-coated TabletAlu/Alu Blister Pack x 10’s (Box of 1 Blister pack x 10 tablets) | Rx | Innova Captab Ltd. (Unit II)India | Pharmasilv TradingImporter: Ambica International Corporation | DRP-14009-02 | Jun 5, 2028 | |
Fixsil-200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's and 50's) | Rx | Zim Laboratories LimitedIndia | Pharmasilv TradingImporter: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-09 | Oct 24, 2027 | |
FixupenCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 100’s | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India | Diafarm Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-2654-04 | Dec 20, 2028 | |
FixxxCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL Box of 1’s | Rx | Zim Laboratories LimitedIndia | Guimhealth Pharmaceutical Distributor & DrugstoreImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-14 | Sep 17, 2029 | |
FixxxCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | XL Laboratories Pvt. Ltd.India | Guimhealth Pharmaceutical Distributor & DrugstoreImporter: Ambica International Corporation | DRP-1268-01 | Jul 25, 2028 | |
FixxxCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu-Alu Blister Pack x 10's Box of 10's | Rx | Zim Laboratories LimitedIndia | Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-08 | Oct 24, 2027 | |
Flamifix 200Cefixime (as trihydrate) | 200 mg CapsuleAlu-Alu Blister Pack x 10's (Box of 10's) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-2459 | Apr 19, 2027 | |
FleximeCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1's); HDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | GPC Geo Pharma CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-15 | Sep 17, 2029 | |
FreximCefixime (as trihydrate) | 100mg/5mL Powder for SuspensionAmber Glass Bottle x 37.5mL and 50mL (Box of 1's) | Rx | Biopharma Laboratories LimitedBangladesh | JF Draf Pharmaceuticals Corporation | DRP-3829 | Jul 9, 2027 | |
FreximCefixime (As trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 5's (Box of 50's) | Rx | Biopharma Laboratories Ltd.Bangladesh | JF Draf Pharmaceuticals Corporation | DRP-2631 | Oct 15, 2030 | |
FroncefCefixime (As Trihydrate) | 100 mg/5 mL Granules For SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Frontida Pharmaceutical Distributor | DRP-5052-13 | Aug 18, 2027 | |
FroncefCefixime | 20 mg / mL Granules for Suspension (Oral Drops)10mL net content bin 15mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Frontida Pharmaceutical Incorporated | DRP-5683-27 | Feb 20, 2029 | |
Geof-CefiximeCefixime (as trihydrate) | 100 mg Powder for Oral SuspensionAlu/PVC Foil Sachet x 2.7 g (Box of 10's) | Rx | Geofman PharmaceuticalsPakistan | Sahar International Trading, Inc. | DRP-4596 | Apr 4, 2029 | |
GeofiximeCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE White Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Geo Pak International Trading Corp.Importer: Accesspoint International Trading Inc. | DRP-5926-03 | Oct 12, 2031 | |
Geofixime DSCefixime (as trihydrate) | 200 mg/5 mL Powder for Oral SuspensionHDPE White Plastic Bottle with Pilfer Proof Cap x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Geo Pak International Trading Corp.Importer: Accesspoint International Trading Inc. | DRP-5931-03 | Jun 20, 2028 | |
GFIXECefixime (as trihydrate) | 20 mg/mL Granules for Suspension (Oral Drops)15 mL in 30 mL Amber Glass Bottle with Dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Ferma Drug EnterprisesTrader: Westfield Pharmaceuticals, Inc. | DRP-10383-03 | Dec 2, 2029 | |
GFIXECefixime (as trihydrate) | 20 mg/mL Granules for Suspension (Oral Drops)15 mL in 30 mL Amber Glass Bottle with Dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | Ferma Drug EnterprisesTrader: Westfield Pharmaceuticals, Inc. | DRP-10383-06 | Dec 2, 2029 | |
GicefixCefixime (as Trihydrate) | 200 mg Dispersible Tablet (Trusil Strawberry Flavor)Alu/Alu Blister Pack x 10's (Box of 10's) | Rx | Innova Captab Pvt. Ltd.India | Gijun Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-13665-01 | Mar 23, 2028 | |
GofixCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL Box of 1's | Rx | Sakar Healthcare LimitedIndia | Applied Pharmaceutical Distribution Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-18 | Nov 27, 2028 | |
GofiximeCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionHDPE bottle with measuring cup x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Applied Pharmaceutical Distribution Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-16268-01 | Jan 16, 2030 | |
GofiximeCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)India | Applied Pharmaceutical Distribution Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-4381-02 | Apr 18, 2028 | |
GracefixCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Glorious Dexa Mandaya, Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-07 | Nov 27, 2028 | |
HezgicefCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL Box of 1's | Rx | Sakar Healthcare Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-15 | Nov 27, 2028 | |
Hilcef 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Swiss Pharma Pvt. Ltd.India | Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7356-08 | Feb 21, 2029 | |
Hilcef 400Cefixime (as trihydrate) | 400 mg Dispersible TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Swiss Pharma Pvt. Ltd.India | Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7357-07 | Feb 26, 2029 | |
HypercefCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1's); HDPE Bottle x 60 mL (Box of 1's) | Rx | Zim Laboratories LimitedIndia | Hypermed CoImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-25 | Sep 17, 2029 | |
HypercefCefixime (as trihydrate) | 20 mg/mL Granules for Suspension (Oral Drops)15 mL in 30 mL Amber Glass Bottle with Dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Hypermed CoTrader: Westfield Pharmaceuticals, Inc. | DRP-10383-01 | Dec 2, 2029 | |
ImiximeCefixime (as trihydrate) | 400 mg CapsuleAlu/Alu Blister Pack x 4's (Box of 4's) | Rx | Incepta Pharmaceuticals Limited (Zirabo Plant)Bangladesh | Ambica International Corporation | DRP-11362 | Mar 4, 2032 | |
IximeCefixime (Anhydrous) | 100mg Chewable tabletAlu/Alu Blister Pack x 10's Box of 10's | Rx | Lupin LimitedIndia | Lupin Philippines Inc | DRP-6190 | Apr 29, 2027 | |
KatryxCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Belasram Farma TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-24 | Sep 17, 2029 | |
KenzocefCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Kenzomed Pharmaceutical Products Trading | DRP-5052-24 | Aug 18, 2027 | |
KENZOCEFCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine Dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | KENZOMED PHARMACEUTICAL PRODUCTS TRADING | DRP-5683-20 | Feb 20, 2029 | |
KENZOCEF DSCefixime (as Trihydrate) | 20 mg/mL Granules for Suspension (Oral Drops)15 mL in 30 mL Amber Glass Bottle with Dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | Kenzomed Pharmaceutical Corp.Trader: Westfield Pharmaceuticals, Inc. | DRP-10383-05 | Dec 2, 2029 | |
KepximeCefixime (As Trihydrate) | 400mg CapsuleAlu/Alu Strip Pack x 10's (Box of 30's) | Rx | Sakar Healthcare Pvt. Ltd.India | Biocare Lifesciences, Inc. | DRP-12501 | Aug 19, 2027 | |
Lefixime 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Innova Captab Ltd.India | Lealmeds Pharmaceutical, Inc.Trader: Pandix Healthcare | DRP-15063 | Apr 2, 2029 | |
Lefixime 400Cefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Innova Captab Ltd.India | Lealmeds Pharmaceutical, Inc.Trader: Pandix Healthcare | DRP-15062 | Apr 2, 2029 | |
LuximeCefixime (as Trihydrate) | 100 mg / 5 mL Granules for SuspensionBoston Round Amber Bottle x 30 mL and 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Lucet Adamas Inc. | DRP-5052-27 | Aug 18, 2027 | |
LuximeCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with Medicine Dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Lucet Adamas Inc. | DRP-5683-24 | Feb 20, 2029 | |
MaedixCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL Box of 1’s | Rx | Zim Laboratories LimitedIndia | Maed Pharma CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-02 | Sep 17, 2029 | |
Maedix 200Cefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10's Box of 10's | Rx | Brawn Laboratories LimitedIndia | Maed Pharma CorporationImporter: Ambica International Corporation | DRP-4051-04 | Oct 16, 2027 | |
Maedix SCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Suspension60 mL HDPE Bottle (Box of 1's) | Rx | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Maed Pharma CorporationImporter: Accesspoint International Trading Inc. | DRP-13909-03 | Apr 5, 2037 | |
Maedix TFCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Maed Pharma CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-23 | Nov 27, 2028 | |
Maedix TFCefixime (as trihydrate) | 50 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | MAED Pharma CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4962-01 | Nov 27, 2028 | |
MagnefixCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's | Rx | Zim Laboratories Ltd.India | Diafarm Inc.Importer: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-02 | Oct 24, 2027 | |
Malcef DSCefixime (as trihydrate) | 200 mg/ 5 mL Powder for Oral SuspensionHDPE White Plastic Bottle with Pilfer Proof Cap x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Malyka International Trading Corp.Importer: Accesspoint International Trading Inc. | DRP-5931-02 | Jun 20, 2028 | |
MaxcimeCefixime (as trihydrate) | 200 mg/5 mL Powder for SuspensionAmber Glass Bottle x 30 mL (Box of 1's) | Rx | Mc Olson Research Laboratories (Pvt) Ltd.Pakistan | Sahar International Trading Inc | DR-XY44997 | Jan 20, 2031 | |
MedicifimeCefixime (As Trihydrate) | 200mg Film Coated TabletAlu-Alu blisters Pack x 10's (Box of 10's and 100's) | Rx | Medley Pharmaceuticals LimitedIndia | Ambica International Corporation | DRP-13683 | Mar 29, 2028 | |
MeedcefixCefixime | 20mg/mL Granules For Suspension (Oral Drops)10mL net content in 15mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Meedpharma Medical Supplies & Equipment Distributor | DRP-5683-29 | Feb 20, 2029 | |
MeximeCefixime (as Trihydrate) | 100 mg / 5 mL Powder for SuspensionHDPE White Bottle x 30mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc. | DRP-5926-04 | Oct 12, 2031 | |
MeximeCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack by 10's in a Box x 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Rexmed Pharmaceutical SalesImporter: Pharmakon Biotec Inc. | DRP-5121-07 | Oct 14, 2028 | |
MeximeCefixime (as trihydrate) | 400 mg Orodispersible TabletAlu/Alu Blister Pack x 10's in Individual Box of 10 Not Applicable | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Rexmed Pharmaceutical SalesImporter: Pharmakon Biotec Inc. | DRP-6669-07 | May 20, 2031 | |
MycefixCefixime Trihydrate | 200 mg Dispersible TabletAlu/Alu Blister Pack x 10 Tablets per Box (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Pharmakon Biotec Inc. | DRP-4749 | Jul 10, 2028 | |
MycefixCefixime (as trihydrate) | 400 mg Orodispersible TabletAlu/Alu Blister Pack x 10's in Individual Box of 10 (Box of 100's); Alu / Alu Blister Pack x 10's (Box of 30's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Pharmakon Biotec Inc. | DRP-6669 | May 20, 2031 | |
MyrecefCefixime (as trihydrate) | 100mg/5mL Powder for SuspensionAmber Bottle x 30mL and 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-2955 | May 5, 2031 | |
MyrecefCefixime (as trihydrate) | 20 mg/mL Powder for Suspension (Oral Drops)10 mL Amber Glass Bottle (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-3151 | Aug 3, 2031 | |
NeocefiximCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1’s); HDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Neo-Care PhilippinesImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-21 | Sep 17, 2029 | |
NexefixCefixime (as Trihydrate) | 200 mg Dispersible TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Teramedix Pharma Trading, Inc.Importer: Pharmakon Biotec, Inc. | DRP-4749-10 | Jul 10, 2028 | |
NibeximeCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Medirich Pharma Distribution Corp. | DRP-5052-23 | Aug 18, 2027 | |
NibeximeCefixime | 20mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp. | DRP-5683-19 | Feb 20, 2029 | |
NoneCefixime (as trihydrate) | 100 mg / 5 mL Powder for Suspension60 mL HDPE Bottle (Box of 1's) | Rx | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Reta DrugImporter: Accesspoint International Trading Inc. | DRP-13909-04 | Feb 15, 2037 | |
NoneCefixime (as Trihydrate) | 100 mg / 5 mL Powder for SuspensionHDPE White Plastic Bottle x 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Reta DrugImporter: Accesspoint International Trading Inc. | DRP-5926-12 | Oct 12, 2031 | |
NoneCefixime (as trihydrate) | 100 mg CapsuleAlu/Alu Blister Pack x 10's Box of 10's | Rx | Brawn Laboratories LimitedIndia | Watsons Personal Care Stores (Philippines), Inc.Importer: Ambica International Corporation | DRP-4438 | May 27, 2028 | |
NoneCefixime (as trihydrate) | 100 mg Oral Powder for Suspension (Mixed Fruits Flavor)60 mL-capacity White HDPE bottle x 60 mL with white HDPE cap and measuring cup (Box of 1’s) | Rx | East African (India) OverseasIndia | PharmaVital Corp.Importer: Ambica International Corporation | DRP-17308-01 | Nov 14, 2030 | |
NoneCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with Medicine Dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | FIRSTMED THERACONCEPT INC. | DRP-5683-14 | Feb 20, 2029 | |
NoneCefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4051-03 | Oct 16, 2027 | |
NoneCefixime | 200 mg CapsuleAluminum Foil Strip x 6's (Box of 30's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DRP-5191 | Sep 6, 2031 | |
NoneCefixime (as trihydrate) | 200 mg CapsuleAlu Foil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Foramen Products CorporationTrader: Metz Pharmaceuticals, Inc. | DRP-8070-02 | Apr 13, 2030 | |
NoneCefixime (as trihydrate) | 200 mg CapsuleAlu Foil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Gamot Philippines, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-8070-03 | Apr 13, 2030 | |
NoneCefixime | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30’s and 100’s) | Rx | Globela Laboratories Private LimitedIndia | Qualifirst Health Inc.Importer: AMB HK Enterprises Inc. | DRP-12216-02 | Jul 6, 2027 | |
NoneCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | XL Laboratories Pvt. Ltd.India | Pharex Health CorporationImporter: Ambica International Corporation | DRP-1268 | Jul 25, 2028 | |
NoneCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 1 Blister pack x 10 tablets) | Rx | Innova Captab Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-14009-06 | Jun 5, 2028 | |
NoneCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 1 Blister Pack x 30 tablets) | Rx | Innova Captab Ltd.India | PharmaVital Corp.Importer: Ambica International Corporation | DRP-14009-07 | Jun 5, 2028 | |
NoneCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 30’s, and 100’s) | Rx | Innova Captab Ltd.India | Rose Pharmacy, IncorporatedImporter: Ambica International Corporation | DRP-14009-08 | Jun 5, 2028 | |
NoneCefixime (as Trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals and Pharmaceuticals Limited)India | International Pharmaceuticals, Inc.Importer: Ambica International Corporation | DRP-3924-01 | Aug 17, 2027 | |
NoneCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Zim Laboratories Ltd.India | ATC Healthcare International Corp.Importer: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-03 | Oct 24, 2027 | |
NoneCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Brawn Laboratories LimitedIndia | TGP Pharma Inc.Importer: Ambica International Corporation | DRP-4709-01 | Sep 13, 2028 | |
NoneCefixime | 20mg/mL Granules for Suspension (Oral Drops)10mL net content in 15mL Boston Round Amber Bottle with Medicine Dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | TGP Pharma Inc. | DRP-5683-25 | Feb 20, 2029 | |
NoneCefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 1 Blister Pack x 10 tablets) | Rx | Innova Captab Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-14010-02 | Jun 5, 2028 | |
NoneCefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 1 Blister Pack x 10 tablets) | Rx | Innova Captab Ltd. (Unit II)India | PharmaVital Corp.Importer: Ambica International Corporation | DRP-14010-03 | Jun 5, 2028 | |
NoraximeCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India | Ambitech Biopharmaceuticals Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-2654-01 | Dec 20, 2028 | |
OfexCefixime (As Trihydrate) | 100 mg/5mL Powder for SuspensionRound Amber Glass Bottle x 50 mL with Medicine Dropper Measuring Spoon and Measuring Cup (Box of 1's) | Rx | Delta Pharma Ltd.Bangladesh | Biomed Pharma Inc. | DR-XY40126 | Oct 5, 2031 | |
Ofex 400Cefixime (As Trihydrate) | 400 mg CapsuleALU-ALU BLISTER PACK X 4'S BOX OF 4'S | Rx | Delta Pharma Ltd.Bangladesh | Biomed Pharma Inc. | DR-XY39680 | Jun 28, 2031 | |
OmniximeCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 30 mL and 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc..Philippines | Cassandras Care Pharmaceutical Distributor | DRP-5052-16 | Aug 18, 2027 | |
OMNIXIMECefixime | 20 mg/mL Granules For Suspension (Oral Drops)10 mL net content in 15 mL Boston round Amber bottle with medicine dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | CASSANDRAS CARE PHARMACEUTICAL DISTRIBUTOR | DRP-5683-08 | Feb 20, 2029 | |
Omnixime-CCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Cassandras Care Pharmaceutical DistributorImporter: Suhitas Pharmaceuticals Inc. | DRP- 14120-01 | Jun 23, 2028 | |
OpiximeCefixime Trihydrate | 200 mg Dispersible TabletAlu/Alu Blister Pack x 10 Tablets per Box (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Orient Pearl Med Pharma Inc.Importer: Pharmakon Biotec Inc. | DRP-4749-12 | Jul 10, 2028 | |
OrafixeCefixime (as Trihydrate) | 200 mg CapsuleAlu/Alu blister pack x 10’s Box of 50’s | Rx | Zim Laboratories LimitedIndia | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: PSA International (Export Division of PSA Chemicals and Pharmaceuticals Pvt. Ltd.) | DRP-1717-01 | Nov 20, 2029 | |
OralimeCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant 1 - Solid Oral Dosage Facility)India | Suhitas Pharmaceuticals Inc. | DRP-4381 | Apr 18, 2028 | |
PediaximeCefixime (as trihydrate) | 100 mg/ 5 mL Powder for SuspensionHDPE White Bottle x 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Base Line Pharma Corp.Importer: Accesspoint International Trading Inc. | DRP-5926-13 | Oct 12, 2031 | |
Pediaxime DSCefixime (as trihydrate) | 200 mg/5 mL Powder for Oral SuspensionHDPE White Plastic Bottle with Pilfer-Proof Cap x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Base Line Pharma Corp.Importer: Accesspoint International Trading Inc. | DRP-5931-04 | Jun 20, 2028 | |
PenximeCefixime (as Trihydrate) | 200 mg CapsuleAlu-Alu Blister Pack x 10's (Box of 10's) | Rx | Flamingo Pharmaceuticals Ltd.India | Planetarium Enterprise, Inc.Importer: Hexagon Pharmaceuticals | DRP-2459-04 | Apr 19, 2027 | |
PointfiximeCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s); Alu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India | Westpoint Pharma Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-2654-07 | Dec 20, 2028 | |
Protexime 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Swiss Pharma Pvt. Ltd.India | Prohansen Pharma Phils. Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7356-09 | Feb 21, 2029 | |
Protexime 400Cefixime (as trihydrate) | 400 mg Dispersible TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Swiss Pharma Pvt. Ltd.India | Prohansen Pharma Phils. Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7357-08 | Feb 26, 2029 | |
Q XefCefixime (as trihydrate) | 20 mg / mL Powder for Oral Suspension (Oral Drops)HDPE plastic bottle with medicine dropper x 30 mL (Box of 1’s) | Rx | Globela Laboratories Private LimitedIndia | Quad-Gen PharmaceuticalsImporter: AMB HK Enterprises Inc. | DRP-12592-02 | Sep 19, 2027 | |
QualifixCefixime (as trihydrate) | 100 mg Oral Powder for Suspension (Chocolate Flavor)60 mL-capacity White HDPE bottle x 60 mL with white HDPE cap and measuring cup (Box of 1's) | Rx | East African (India) OverseasIndia | Applied Pharmaceutical Distribution IncImporter: Ambica International Corporation | DRP-17310-02 | Nov 14, 2030 | |
QuixCefixime Trihydrate | 200 mg Dispersible TabletAlu/Alu Blister Pack x 10 tablets per Box (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Ellebasy Medicale TradingImporter: Pharmakon Biotec Inc. | DRP-4749-01 | Jul 10, 2028 | |
QuixCefixime (as trihydrate) | 400 mg Orodispersible TabletAlu/Alu Blister Pack x 10's in Individual Box of 10 (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Ellebasy Medicale TradingImporter: Pharmakon Biotec Inc. | DRP-6669-02 | May 20, 2031 | |
RefixCefixime (as trihydrate) | 100 mg/5 mL Granules for Oral Suspension60 mL white translucent HDPE bottle with white LDPE flip top cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY49493 | Sep 5, 2030 | |
RefixCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma Inc. | DR-XY42199 | Jul 10, 2028 | |
Refixime-DSCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL and 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-03 | Sep 17, 2029 | |
RegifixCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 1 Blister Pack x 30 tablets) | Rx | Innova Captab Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-14009-03 | Jun 5, 2028 | |
RetaximeCefixime | 20 mg/mL Granules For Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | APPEX MD'S PHARMACEUTICAL INC. | DRP-5683-04 | Feb 20, 2029 | |
RetracefCefixime (as Trihydrate) | 100 mg/ 5 mL Granules for SuspensionBoston Round Amber Bottle x 60 mL | Rx | Lloyd Laboratories, Inc.Philippines | Remed Pharmaceuticals, Inc.Trader: Solvang Pharmaceuticals, Inc. | DRP-8429-01 | Sep 13, 2027 | |
RetracefCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionAmber Glass Bottle x 37.5 mL (Box of 1's) | Rx | The ACME Laboratories LimitedBangladesh | Remed Pharmaceuticals, Inc.Importer: Euro Generics International Philippines, Inc. | DRP-2403-01 | Mar 14, 2028 | |
RexmecefCefixime (as trihydrate) | 100 mg / 5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Sakar Healthcare Ltd.India | Rexmed Pharmaceutical SalesImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-25 | Nov 27, 2028 | |
RexmecefCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL Box of 1's; HDPE Bottle x 60 mL Box of 1’s | Rx | Zim Laboratories LimitedIndia | Rexmed Pharmaceuticals SalesImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-17 | Sep 17, 2029 | |
RexmecefCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10mL net content in 15mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Rexmed Pharmaceutical Sales | DRP-5683-30 | Feb 20, 2029 | |
Rexmecef 200Cefixime (as trihydrate) | 200 mg Film Coated TabletAlu/Alu Blister Pack x 10's Box of 20's | Rx | Swiss Pharma Pvt. Ltd.India | Rexmed Pharmaceuticals SalesImporter: Sanimed Pharmaceuticals Inc. | DRP-7356-02 | Feb 21, 2029 | |
Rexmecef 400Cefixime (as trihydrate) | 400 mg Dispersible TabletAlu/Alu Blister Pack x 10's Box of 10's | Rx | Swiss Pharma Pvt. Ltd.India | Rexmed Pharmaceuticals, Inc.Importer: Sanimed Pharmaceuticals | DRP-7357-02 | Feb 26, 2029 | |
RezefCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | R.E. PHARMACEUTICALS | DRP-5052-26 | Aug 18, 2027 | |
RobetrixCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | RSG Pharma TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-20 | Sep 17, 2029 | |
SANFIX 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Swiss Pharma Pvt. Ltd.India | Sanimed Pharmaceuticals Inc. | DRP-7356 | Feb 21, 2029 | |
SANFIX 400Cefixime (as trihydrate) | 400 mg Dispersible TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Swiss Pharma Pvt. Ltd.India | Sanimed Pharmaceuticals Inc. | DRP-7357 | Feb 26, 2029 | |
Saphixime 200Cefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10's Box of 10's and 30's | Rx | SAPPHIRE LIFESCIENCES PVT. LTDIndia | NELPA LIFESCIENCES, INC. | DRP-8385 | Nov 16, 2027 | |
Saphixime 400Cefixime (as trihydrate) | 400 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10's); Alu/Alu Blister Pack x 10's (Box of 100's) | Rx | SAPPHIRE LIFESCIENCES PVT. LTDIndia | NELPA LIFESCIENCES, INC. | DRP-8386 | Nov 16, 2027 | |
SavecefCefixime (as trihydrate) | 100 mg CapsuleAlu/Alu Blister pack x 10 capsules Box of 10’s | Rx | Maxim Pharmaceuticals Pvt., Ltd.India | Importer: SRS Life Sciences Inc.Trader: SRS Pharmaceuticals Pvt. Ltd. | DRP-839 | Dec 11, 2030 | |
SavecefCefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister pack x 10 capsules Box of 10’s | Rx | Maxim Pharmaceuticals Pvt., Ltd.India | Importer: SRS Life Sciences Inc.Trader: SRS Pharmaceuticals Pvt. Ltd. | DRP-838 | Dec 11, 2030 | |
SeptipanCefixime (as Trihydrate) | 100 mg/5 mL Powder for Oral SuspensionUSP Type II Amber Glass Bottle with measuring cup and spoon x 30 mL and 60 mL (Box of 1's) | Rx | Geofman PharmaceuticalsPakistan | Sahar International Trading Inc. | DRP-2633 | Mar 9, 2029 | |
SeptipanCefixime (as Trihydrate) | 400 mg CapsuleAlu/Alu Blister Pack x 5's (Box of 10's) | Rx | GEOFMAN PHARMACEUTICALSPakistan | SAHAR INTERNATIONAL TRADING INC. | DR-XY41075 | Jul 24, 2027 | |
SetacefCefixime (as trihydrate) | 100 mg / 5 mL Powder for Suspension60 mL HDPE Bottle (Box of 1's) | Rx | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Eliset Pharmaceutical, Inc.Importer: Accesspoint International Trading Inc. | DRP-13909-01 | Mar 2, 2037 | |
Sevixime-200Cefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | 777 Red Pharma, Inc.Importer: Nelpa Lifesciences, Inc. | DRP-8385-01 | Nov 16, 2027 | |
Sevixime-200Cefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10’s); Alu/Alu Blister Pack x 10's (Box of 30’s) | Rx | Sunlovis Pharmaceuticals LLP.India | 777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-8385-03 | Nov 16, 2027 | |
Sevixime-400Cefixime (as trihydrate) | 400 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | 777 Red Pharma, Inc.Importer: Nelpa Lifesciences, Inc. | DRP-8386-01 | Nov 16, 2027 | |
Sevixime-400Cefixime (as trihydrate) | 400 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10’s); Alu/Alu Blister Pack x 10's (Box of 100’s) | Rx | Sunlovis Pharmaceuticals LLPIndia | 777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-8386-03 | Nov 16, 2027 | |
ShefixCefixime (as Trihydrate) | 100 mg / 5 mL Powder for SuspensionHDPE White Plastic Bottle x 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Kain's Trading Corp.Importer: Accesspoint International Trading Inc. | DRP-5926-10 | Oct 12, 2031 | |
SITIFIXCefixime ( as trihydrate) | 100 mg/5 mL Granules for SuspensionAmber glass Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Bosch Pharmaceuticals (Pvt) Ltd.Korangi Industrial Area Karachi Pakistan | Sahar International Trading Inc. | DRP-13567 | Aug 14, 2031 | |
SonicephCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Sonchel Pharma DistributorsImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-10 | Sep 17, 2029 | |
SonicephCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Sonchel Pharma DistributorsImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-22 | Nov 27, 2028 | |
Starfix 200Cefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10’s (Box of 10’s and 30’s) | Rx | Sunlovis Pharmaceuticals LLP..India | Pharmastar Int'l Trading CorpImporter: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-8385-02 | Nov 16, 2027 | |
Starfix 400Cefixime (as trihydrate) | 400 mg CapsuleAlu/Alu Blister Pack x 10’s (Box of 10’s ); Alu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Sunlovis Pharmaceuticals LLP.India | Pharmastar Int'l Trading Corp.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-8386-02 | Nov 16, 2027 | |
SuficeCefixime (as Trihydrate) | 200 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Theon Pharmaceuticals Ltd.India | Iberica Verheilen Pharmaceuticals Group Corp.Importer: Verheilen Iberica Health Care Company Inc.Trader: Farma Iberica S.L. | DRP-3234 | Sep 7, 2031 | |
SufiximeCefixime (as trihydrate) | 100 mg/5 mL Granules for SupensionBoston Round Amber Bottle x 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Summa Medicus Corporation | DRP-5052-28 | Aug 18, 2027 | |
Supixime -100Cefixime (as trihydrate) | 100 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Micro Labs LimitedIndia | Brown & Burk Philippines Inc. | DRP-5688 | Jun 4, 2028 | |
Supixime -200Cefixime ( as trihydrate ) | 200 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10's and 30's) | Rx | Micro labs LimitedIndia | Applied Pharmaceutical Distribution Inc.Importer: Brown & Burk Philippines Inc | DRP-5687 | Jun 3, 2028 | |
Supixime -400Cefixime ( as trihydrate) | 400 mg CapsulePVC/PVDC Blister Pack x 6's (Box of 6's); PVC/PVDC Blister Pack 3 x 10's (Box of 30's) | Rx | Micro Labs LimitedIndia | Brown & Burk Philippines Inc.Importer: Brown & Burk Philippines inc. | DR-XY43632 | Aug 15, 2029 | |
Supixime -400Cefixime ( as trihydrate) | 400 mg capsulePVC/ PVDC Blister Pack x 6's / (Box of 6's): PVC/PVDC Blister Pack 3 x 10's / (Box of 30's) | Rx | Micro Labs LimitedIndia | Brown & Burk Philippines Inc. | DRP-15163 | Aug 15, 2029 | |
Suprafix DSCefixime (As Trihydrate) | 100 mg/5 mL (20 mg/mL) Powder For Oral SuspensionHDPE plastic bottle x 30 mL and 60 mL (Box of 1's) | Rx | NGB Laboratories Pvt. Ltd.India | FSPC Pharmaceuticals Inc. | DRP-12591 | Sep 19, 2027 | |
Suprafix DSCefixime (As Trihydrate) | 20mg/mL Powder for Oral Suspension (Oral Drops)HDPE plastic bottle with medicine dropper x 10 mL and 30 mL (Box of 1's) | Rx | NGB Laboratories Pvt. Ltd.India | FSPC Pharmaceuticals Inc. | DRP-12592 | Sep 19, 2027 | |
Supraphil 200Cefixime | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | NGB Laboratories Pvt. Ltd.India | PhilRx Pharma Inc.Importer: AMB HK Enteprises Inc. | DRP-12216-01 | Jul 6, 2027 | |
SusfixefCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL Box of 1's | Rx | Sakar Healthcare LimitedIndia | Diafarm Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-16 | Nov 27, 2028 | |
Taxim-OCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack by 10's in a Box x 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Alkem Laboratories CorporationImporter: Pharmakon Biotec Inc. | DRP-5121-13 | Oct 14, 2028 | |
Taxim-OCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/ Alu Blister Pack x 10's Box of 10's; Alu/ Alu Blister Pack x 10's Box of 50's | Rx | ALKEM LABORATORIES LIMITEDIndia | ALKEM LABORATORIES CORPORATION | DRP-5618 | Sep 6, 2028 | |
Taxim-O 400Cefixime (as trihydrate) | 400 mg Orodispersible TabletAlu/Alu Blister Pack x 10's (Box of 30's); Alu/Alu Blister Pack x 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Alkem Laboratories CorporationImporter: Pharmakon Biotec Inc. | DRP-6669-03 | May 20, 2031 | |
Taxim-O KidsCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare LimitedIndia | Alkem Laboratories CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-19 | Nov 27, 2028 | |
TechmecefCefixime (as trihydrate) | 200 mg Dispersible Tablet (Trusil Strawberry Flavor)Alu/Alu Blister Pack x 10's (Box of 10's) | Rx | Innova Captab Ltd.India | One Technodrug Life Sciences Inc.Importer: Pharmakon Biotec Inc. | DRP-13665-03 | Mar 23, 2028 | |
TergecefCefixime | 100 mg CapsuleFlexible Foil x 10's (Box of 50's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY15861 | Apr 22, 2029 | |
TergecefCefixime | 100 mg/ 5 mL Granules for SuspensionUSP Type III Amber Glass Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Mandaluyong City | Trader: UNILAB, Inc. | DRP-10760 | Sep 25, 2031 | |
TergecefCefixime | 20 mg/mL Granules for Suspension (Drops)10 mL Aries Bottle (22 mm metal closures) with Medicine Dropper (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DRP-12708 | Nov 17, 2029 | |
TergecefCefixime | 200 mg CapsuleAluminum Foil Strip x 6's (Box of 30's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY16196 | Jun 30, 2036 | |
Tergecef ODCefixime | 400 mg CapsuleAluminum Foil Strip x 6's (Box of 30's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Unilab Inc. | DR-XY35403 | Feb 4, 2029 | |
TeriximeCefixime (as trihydrate) | 100 mg/ 5 mL Granules for SuspensionBoston Round Amber Bottle x 30 mL and 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | CHMI PHARMA, INC. | DRP-5052-33 | Aug 18, 2027 | |
TerracefCefixime (as trihydrate) | 100 mg / 5 mL (20 mg / mL) Powder for Oral SuspensionHDPE plastic bottle x 30 mL and 60 mL (Box of l's) | Rx | Globela Laboratories Pvt. Ltd.India | Terramedic, Inc.Importer: AMB HK Enterprises Inc. | DRP-12591-06 | Sep 19, 2027 | |
TerracefCefixime (as trihydrate) | 20 mg/mL Powder for Suspension (Oral Drops)15 mL Amber Boston Glass Bottle (10 mL as net content) with Plastic Medicine Dropper x 1 mL (Box of 1's) | Rx | Drugmaker's Laboratories, inc.Philippines | Terramedic, Inc. | DRP-6417-01 | Mar 19, 2027 | |
Terracef 200Cefixime (as Trihydrate) | 200 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 10's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Terramedic, Inc. | DRP-16584-01 | May 8, 2027 | |
TgximeCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 30 mL and 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | TGIF Pharmaceutical Trading. | DRP-5052-09 | Aug 18, 2027 | |
TGXIMECefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine Dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | TGIF PHARMACEUTICAL TRADING INC. | DRP-5683-16 | Feb 20, 2029 | |
TGXIMECefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack by 10's in a Box x 10's (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | TGIF Pharmaceutical Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-5121-14 | Oct 14, 2028 | |
ThrecefCefixime (as Trihydrate) | 200 mg CapsuleAlu Strip Foil x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Randril Internation Co., Inc. | DRP-15578 | Apr 24, 2030 | |
Trifix 200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Foil Strip Pack x 10's (Box of 20's) | Rx | Celogen Pharma Pvt. LtdIndia | Pharmastar Int'l Trading Corp. | DRP-8648 | Sep 26, 2029 | |
TrifiximeCefixime (as Trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 60 mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-8429 | Sep 13, 2027 | |
TrifiximeCefixime (as Trihydrate) | 200 mg CapsuleAluminum Foil Strip x 10's (Box of 50's and 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-8673 | Mar 12, 2027 | |
TrihydcefCefixime (as Trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 4's (Box of 4's) | Rx | XL Laboratories Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-3859-01 | Jul 24, 2027 | |
TrimaxCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Curasave PharmaImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-04 | Sep 17, 2029 | |
TrimaxCefixime (as Trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals and Pharmaceuticals Ltd.)India | Checktrade Pharma, Inc.Importer: Ambica International Corporation | DRP-3924-02 | Aug 17, 2027 | |
TrinifixCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Trinity Health Pharma InternationalImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-18 | Sep 17, 2029 | |
TriocefCefixime (As Trihydrate) | 100 mg/5 mL Granules For SuspensionBoston Round Amber Bottle x 30 mL and 60 mL (Box of l's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | The Cathay Drug Co., Inc. | DRP-5052-17 | Aug 18, 2027 | |
TriocefCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | The Cathay Drug Co., Inc. | DRP-5683-10 | Feb 20, 2029 | |
TriocefCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India | The Cathay Drug Co., Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-2654-03 | Dec 20, 2028 | |
TriocefCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's) | Rx | Zim Laboratories LimitedIndia | The Cathay Drug Co., Inc.Importer: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072-11 | Oct 24, 2027 | |
TriocefCefixime (as trihydrate) | 400 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 1 blister pack x 10 tablets) | Rx | Innova Captab Ltd. (Unit II)India | The Cathay Drug Co., Inc.Importer: Ambica International Corporation | DRP-14010-01 | Jun 5, 2028 | |
TriocefCefixime (as Trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 4's (Box of 4's) | Rx | XL Laboratories Pvt. Ltd.India | The Cathay Drug Co., Inc.Importer: Ambica International Corporation | DRP-3859 | Jul 24, 2027 | |
TriocefCefixime (as trihydrate) | 400 mg Orodispersible TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Scott-Edil Advance Research Laboratories & Education Ltd.India | The Cathay Drug Co., Inc.Importer: Pharmakon Biotec Inc. | DRP-6669-05 | May 20, 2031 | |
Triocef PFOSCefixime (as trihydrate) | 100 mg /5 ml Powder for Oral SuspensionHDPE bottle with measuring cup x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | The Cathay Drug Co., Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-16268-04 | Jan 16, 2030 | |
Triocef PFOSCefixime (as Trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE White Plastic Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | The Cathay Drug Co., Inc.Importer: Accesspoint International Trading Inc. | DRP-5926-15 | Oct 12, 2031 | |
Triocef PFOSCefixime (as trihydrate) | 100 mg/5mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1’s) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant 1 - Solid Oral Dosage Facility)India | The Cathay Drug Co., Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-4381-03 | Apr 18, 2028 | |
TriolevCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE bottle with measuring cup x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-16268-02 | Jan 16, 2030 | |
Triolev-200Cefixime (as trihydrate) | 200 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Innova Captab Ltd.India | HLM Pharmaceutical Inc.Importer: Ambica International Corporation | DRP-14009-05 | Jun 5, 2028 | |
Triolev-200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s); Alu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India | HLM Pharmaceutical Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-2654-06 | Dec 20, 2028 | |
TriozimeCefixime (as trihydrate) | 200 mg CapsuleAlu Foil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-8070 | Apr 13, 2030 | |
TropsivCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 30 mL and 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Vispomed Corporation | DRP-5052-15 | Aug 18, 2027 | |
TropsivCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | VISPOMED CORPORATION | DRP-5683-22 | Feb 20, 2029 | |
TruquestCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionPackaging: Boston Round Amber Bottle x 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Health-Quest Pharma and Medical Supplies Trading | DRP-5052-22 | Aug 18, 2027 | |
TruquestCefixime | 20 mg/ mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Health-Quest Pharma and Medical Supplies Trading | DRP-5683-18 | Feb 20, 2029 | |
TyphofixCefixime (as trihydrate) | 200 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | Speed Cure PharmaImporter: Ambica International Corporation | DRP-4051-01 | Oct 16, 2027 | |
Typhofix-DsCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Speed Cure PharmaImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-08 | Sep 17, 2029 | |
UcefixCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL (Box of 1’s); HDPE Bottle x 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Universal MBF Pharma (UMP), Co.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-22 | Sep 17, 2029 | |
UcefixCefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with Medicine Dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Universal MBF Pharma (UMP), Co. | DRP-5683-09 | Feb 20, 2029 | |
UltraximeCefixime | 100 mg / 5 mL Granules for Suspension (Strawberry Flavor)USP Type III Amber bottle x 30 mL and 60 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY23852 | Feb 11, 2028 | |
UltraximeCefixime | 100 mg/5 mL Granules For Suspension (Strawberry Flavor)USP Type III Amber Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DRP-12887 | Jan 31, 2029 | |
UltraximeCefixime | 20 mg per mL Granules For Suspension (Drops)10 mL in 15 mL capacity USP Type III Amber Bottle with dropper (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc.. | DRP-14303 | Sep 29, 2028 | |
UltraximeCefixime | 20 mg per mL Granules for Suspension (Oral Drops)10 mL in 15 mL capacity USP Type III Amber Bottle with Dropper (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY23851 | Feb 11, 2028 | |
UltraximeCefixime | 200mg/5mL Granules for Oral Suspension (Strawberry Flavor)120mL-Capacity Type III Amber Glass Bottle with PP Screw-on Cap with Liner x 1's + Plastic Measuring Cup x 60 mL (Net Content) (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | N/ATrader: UNILAB, Inc. | DRP-17725 | Feb 23, 2031 | |
Umexim-200Cefixime (as Trihydrate) | 200 mg CapsuleAlu-Alu Blister Pack x 10's (Box of 10's, 30's, and 100's) | Rx | Umedica Laboratories Pvt. Ltd.India | Eon Pharmatek Inc. | DR-XY41346 | Oct 30, 2032 | |
UnbrandedCefixime (as trihydrate) | 100 mg / 5 mL Granules for SuspensionAmber Glass Bottle x 30 mL and 60 mL (Box of 1’s) | Rx | Bosch Pharmaceuticals (Pvt.) Ltd.Pakistan | Amson PharmaceuticalsImporter: Sahar International Trading Inc | DRP-13567-01 | Aug 14, 2031 | |
UnbrandedCefixime (as trihydrate) | 20 mg/mL Powder for Suspension (Oral Drops)15 mL Amber Boston Glass Bottle (10 mL as net content) with Plastic Medicine Dropper x 1 mL (Box of 1's) | Rx | Drugmaker’s Laboratories Inc.Laguna | — | DRP-6417 | Mar 19, 2032 | |
UnbrandedCefixime (as Trihydrate) | 200mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 10's) | Rx | Drugmaker's Laboratories, IncPhilippines | — | DR-XY44516 | May 8, 2027 | |
UnbrandedCefixime (as Trihydrate) | 200mg CapsuleAlu/Clear PVC Blister pack x 10's (Box of 10's) | Rx | Drugmakers Laboratories Inc.Philippines | — | DRP-16584 | May 8, 2027 | |
Unifix-200Cefixime (as Trihydrate) | 200 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 10’s) | Rx | Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals and Pharmaceuticals Limited)India | JBCPL Philippines Inc. | DRP-3924 | Aug 17, 2027 | |
UniximeCefixime (as trihydrate) | 20 mg/mL Granules for Suspension (Oral Drops)15 mL in 30 mL Amber Bottle with Dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Universal MBF Pharma (UMP), Co.Trader: Westfield Pharmaceuticals, Inc. | DRP-10383-02 | Dec 2, 2029 | |
UnofixCefixime Trihydrate | 200 mg Dispersible TabletAlu / Alu Blister Pack x 10 Tablets per Box (Box of 100's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-4749-09 | Jul 10, 2028 | |
UnofixCefixime (as trihydrate) | 200 mg Dispersible Tablet (Trusil Strawberry Flavor)Alu/Alu Blister Pack x 10's (Box of 10's) | Rx | lnnova Captab Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-13665-02 | Mar 23, 2028 | |
Unofix-400Cefixime (as trihydrate) | 400 mg Orodispersible TabletAlu/Alu Blister Pack x 10's in Individual Box of 10 (Box of 100's); Alu/Alu Blister Pack x 10's (Box of 30's) | Rx | Scott - Edil Advance Research Laboratories & Education Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-6669-06 | May 20, 2031 | |
VamocefCefixime (as Trihydrate) | 100 mg/5 mL Granules for SuspensionAmber Glass Bottle x 60 mL (Box of 1's); Amber Glass Bottle x 30 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DRP-8468 | Sep 4, 2028 | |
VamocefCefixime (as trihydrate) | 20 mg/mL Powder for Suspension (Oral Drops)Amber Bottle x 10 mL (Box of 1's); Amber Bottle x 30 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DR-XY40852 | May 3, 2027 | |
VamocefCefixime (as Trihydrate) | 200 mg CapsleAlu Foil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DR-XY44294 | Apr 13, 2030 | |
Vcef 200Cefixime (as trihydrate) | 200mg Film-Coated Tablet | Rx | East African (India) OverseasIndia | Divjot Enterprises Corp. | DR-XY49654 | Feb 25, 2031 | |
Vcef 200Cefixime (as trihydrate) | 200mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | East African (India) OverseasIndia | Importer: Divjot Enterprises Corp. | DRP-17921 | Feb 25, 2031 | |
Vcef 400Cefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | East African (India) OverseasIndia | Divjot Enterprises Corp. | DR-XY49609 | Jan 19, 2031 | |
Vcef 400Cefixime (as trihydrate) | 400 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | East African (India) OverseasIndia | Divjot Enterprises Corp. | DRP-17909 | Jan 19, 2031 | |
Viprax-100 DTCefixime (as trihydrate) | Dispersible Tablet 100 mgAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Zim Laboratories Ltd.India | Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-5241 | Apr 3, 2029 | |
Viprax-200Cefixime (as trihydrate) | 200 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's and 50's) | Rx | Zim Laboratories LimitedIndia | GPC Geo Pharma CorporationImporter: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-4072 | Oct 24, 2027 | |
Viprax-DSCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | GPC Geo Pharma CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-05 | Nov 27, 2028 | |
Virexim-DSCefixime (as trihydrate) | 100 mg Oral Powder for Suspension (Chocolate Flavor)60 mL-capacity White HDPE bottle x 60 mL with white HDPE cap and measuring cup (Box of 1's) | Rx | East African (India) OverseasIndia | Ambica International Corporation | DRP-17310 | Nov 14, 2030 | |
Virexim-DSCefixime (as trihydrate) | 100 mg Oral Powder for Suspension (Mixed Fruits Flavor)60 mL-capacity White HDPE bottle x 60 mL with white HDPE cap and measuring cup (Box of 1's) | Rx | East African (India) OverseasIndia | Ambica International Corporation | DRP-17308 | Nov 14, 2030 | |
Virexim-DSCefixime (as trihydrate) | 100 mg Oral Powder for Suspension (Strawberry Flavor)60 mL-capacity White HDPE bottle x 60 mL with white HDPE cap and measuring cup (Box of 1's) | Rx | East African (India) OverseasIndia | Ambica International Corporation | DRP-17309 | Nov 14, 2030 | |
Virexim-DSCefixime (as trihydrate) | 100 mg Powder for Suspension (Lemon Flavor)60 mL-capacity White HDPE bottle x 60 mL with white HDPE cap and measuring cup (Box of 1's) | Rx | East African (India) OverseasIndia | Ambica International Corporation | DRP-17229 | Oct 23, 2030 | |
Vispoxime-DSCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Biotechnica Medical EnterprisesImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-06 | Nov 27, 2028 | |
Vitaxime-200Cefixime (as trihydrate) | 200 mg CapsuleAlu Foil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Vitalink Health Products, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-8070-01 | Apr 13, 2030 | |
WindcefCefixime (as Trihydrate) | 200 mg Film-Coated TabletAlu/Foil Strip Pack x 10's (Box of 20's) | Rx | Celogen Pharma Pvt. Ltd.India | Healthwinds Medical Trading Corp.Importer: Pharmastar Int'l Trading Corp. | DRP-8648-01 | Sep 26, 2029 | |
XifixCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL with measuring cup (Box of 1's) | Rx | East African (India) OverseasIndia | Airlife International Trading Corporation | DRP-17786 | Mar 11, 2031 | |
XimebacCefixime (as trihydrate) | 100 mg/5 mL Granules for SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp. | DRP-5052-01 | Aug 18, 2027 | |
XimebacCefixime | 20 mg/mL Granules For Suspension (Oral Drops)10mL net content in 15mL Boston Round Amber Bottle with medicine dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp. | DRP-5683-02 | Feb 20, 2029 | |
XimebacCefixime (as trihydrate) | 200 mg CapsuleAlu Foil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Metz Pharmaceuticals, Inc. | DRP-8070-05 | Apr 13, 2030 | |
XimetazCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE bottle with measuring cup x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Ellebasy Medicale TradingImporter: Suhitas Pharmaceuticals Inc. | DRP-16268-03 | Jan 16, 2030 | |
XimexCefixime (as trihydrate) | 100 mg/ 5 mL Granules for SuspensionBoston Round Amber Bottle x 60 mL with Polypropylene measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Care First Trading | DRP-5052-31 | Aug 18, 2027 | |
XymecareCefixime (as trihydrate) | 100 mg/5 mL Powder for Suspension60 mL HDPE Bottle (Box of 1's) | Rx | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Medcare PharmaceuticalsImporter: Accesspoint International Trading Inc. | DRP-13909-02 | Mar 6, 2037 | |
Z-FixCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL Box of 1’s; HDPE Bottle x 60 mL Box of 1’s | Rx | Zim Laboratories LimitedIndia | Zyre Pharmaceuticals CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518-07 | Sep 17, 2029 | |
ZefaximCefixime (as trihydrate) | 100 mg/5 mL Powder for Suspension60 mL in 120 mL Amber Glass Bottle with measuring spoon and cup (Box of 1's) | Rx | Platinum Pharmaceuticals (Pvt) Ltd.Pakistan | Wert Philippines, Inc. | DR-XY38578 | Oct 5, 2030 | |
ZefifarmCefixime (as trihydrate) | 100 mg/ 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL Box of 1's; HDPE Bottle x 60 mL Box of 1's | Rx | Zim Laboratories LimitedIndia | Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5518 | Sep 17, 2029 | |
ZefimeCefixime (as trihydrate) | 100 mg/5 mL Powder for Oral SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Kaufmann Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4185-02 | Jan 28, 2028 | |
ZefimedCefixime (as trihydrate) | 100 mg CapsuleAlu Foil Strip x 6's (Box of 30's); Alu Foil Strip x 10's (Box of 10's) | Rx | Azarias Pharmaceutical Laboratories Inc.,Philippines | — | DRP-11396 | Mar 8, 2027 | |
ZefimedCefixime (as trihydrate) | 400 mg CapsuleAlu Strip Foil Pack x 6's (Box of 30's); Alu Strip Foil Pack x 10's (Box of 10's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-10428 | Oct 13, 2031 | |
ZefirCefixime (as trihydrate) | 200 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of Blister pack x 10 tablets) | Rx | Innova Captab Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-14009-04 | Jun 8, 2028 | |
ZefixCefixime (as trihydrate) | 200 mg Dispersible TabletIn a box of 3 Alu-Alu Blister Pack x 10's | Rx | Baroque Pharmaceuticals Pvt. Ltd.India | Endure Medical, Inc. | DR-XY43631 | Aug 15, 2029 | |
ZefixmedCefixime (as trihydrate) | 100 mg/5 mL Powder for SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Sakar Healthcare Pvt. Ltd.India | Medlink Pharma Phils., Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4961-02 | Nov 27, 2028 | |
ZefralCefixime (as trihydrate) | 100 mg CapsuleFoil Strip x 10's (Box of 50's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY19363 | Jan 13, 2031 | |
Zelpis ODCefixime (as trihydrate) | 20 mg/mL Powder for Oral Suspension (Oral Drops)HDPE plastic bottle with medicine dropper x 30 mL (Box of 1’s) | Rx | Globela Laboratories Pvt. Ltd.India | Kaufmann Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12592-03 | Sep 19, 2027 | |
Zelpis-100Cefixime (as trihydrate) | 100 mg/5 mL (20 mg/mL) Powder for Oral SuspensionHDPE plastic bottle x 60 mL (Box of 1’s) | Rx | Globela Laboratories Pvt. Ltd.India | Kaufmann Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12591-03 | Sep 19, 2027 | |
ZemfixCefixime (as trihydrate) | 200 mg CapsuleAlu-Alu Blister Pack of 10's (Box of 10's) | Rx | Flamingo Pharmaceuticals Ltd.India | Labmate Pharma Inc.Importer: Hexagon Pharmaceuticals | DRP-2459-01 | Apr 19, 2027 | |
ZERRIOXIMECefixime | 20 mg/mL Granules for Suspension (Oral Drops)10 mL net content in 15 mL Boston Round Amber Bottle with medicine Dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | KODAPHARM MED CORP. | DRP-5683-21 | Feb 20, 2029 | |
(no brand name)Cefixime (as trihydrate) | 100 mg CapsuleAlu/Alu PVC Blister Pack x 10's (Box of 100's) | Rx | Medico Remedies LimitedIndia | Medethix, Inc. | DRP-14418 | Sep 6, 2028 | |
(no brand name)Cefixime (as trihydrate) | 100mg/5mL Granules For SuspensionBoston Round Amber Bottle x 30 mL and 60 mL (Box of 1's) | Rx | J.M. Tolmann LaboratoriesPhilippines | Firstmed Theraconcept Inc. | DRP-5052-19 | Aug 18, 2027 | |
(no brand name)Cefixime (as trihydrate) | 200 mg CapsuleAluminum Foil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories Inc.Philippines | — | DRP-10825 | Nov 29, 2026 | |
(no brand name)Cefixime (as trihydrate) | 200 mg CapsuleAlu/Alu PVC Blister Pack x 10's (Box of 100's) | Rx | Medico Remedies LimitedIndia | Medethix, Inc. | DRP-14446 | Sep 6, 2028 | |
(no brand name)Cefixime (as trihydrate) | 200 mg Film-Coated TabletPVC/PVDC Aluminum Foil Blister Pack x 10's (Box of 10's) | Rx | Nectar Lifesciences Limited (Unit VI)India | Onesource Pharma Solutions, Inc. | DRP-12034 | Jun 1, 2027 | |
(no brand name)Cefixime (as trihydrate) | 400 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 10 blister packs x 10's) | Rx | Medico REmedies LimitedIndia | Medethix, Inc. | DRP-13935 | May 18, 2028 | |
(no brand name)Cefixime (as trihydrate) | 400 mg Film-Coated TabletPVC/PVDC Aluminum Foil Blister Pack x 10's (Box of 10's) | Rx | Nectar Lifesciences Limited (Unit VI)India | Onesource Pharma Solutions, Inc. | DRP-12033 | Jun 1, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
United States (label)
Dosage forms and strengths (US label) US FDA label
3 DOSAGE FORMS AND STRENGTHS Oral Suspension: 100 mg/5 mL and 200 mg/5 mL (3) Capsules: 400mg (3) Cefixime for oral suspension USP is available for oral administration in a powder for oral suspension, when reconstituted, provides either 100 mg/5 mL or 200 mg/5 mL of cefixime as trihydrate. The powder has an off white to pale yellow color and is strawberry flavored.
Cefixime capsule is available for oral administration as capsules which provide 400 mg of cefixime as trihydrate. These are size "0" capsules with pink opaque cap and pink opaque body, imprinted with "LU" on the cap and "U43" on the body in black ink. Capsules contain white to yellowish white granular powder.
Warnings/Precautions
- Hypersensitivity reactions including shock and fatalities have been reported with cefixime. Discontinue use if a reaction occurs. (5.1)
- Clostridiodes difficile- Associated Diarrhea: Evaluate if diarrhea occurs. (5.2)
5.1 Hypersensitivity Reactions
5.1 Hypersensitivity Reactions Anaphylactic/anaphylactoid reactions (including shock and fatalities) have been reported with the use of cefixime. Before therapy with cefixime is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cephalosporins, penicillins, or other drugs.
If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. If an allergic reaction to cefixime occurs, discontinue the drug.
5.2 Clostridioides difficile
5.2 Clostridioides difficile -Associated Diarrhea Clostridium difficile- associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including cefixime, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.
C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing isolates of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibacterial drug use.
Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibacterial drug use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial drug treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.
5.3 Dose Adjustment in Renal Impairment
5.3 Dose Adjustment in Renal Impairment The dose of cefixime should be adjusted in patients with renal impairment as well as those undergoing continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD). Patients on dialysis should be monitored carefully [see Dosage and Administration (2)].
5.4 Coagulation Effects
5.4 Coagulation Effects Cephalosporins, including cefixime, may be associated with a fall in prothrombin activity. Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy.
Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated.
5.5 Development of Drug-Resistant Bacteria
5.5 Development of Drug-Resistant Bacteria Prescribing cefixime in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.
Drug interactions
| Drug or class | Severity | Effect | What to do |
|---|---|---|---|
| Carbamazepine | Adjust or monitor | Higher carbamazepine levels reported (label). | Monitor carbamazepine levels. |
| Warfarin and other oral anticoagulants | Adjust or monitor | Prolonged prothrombin time / higher INR reported (label). | Monitor INR. |
Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.
renalcarematters.com, reviewed- Elevated carbamazepine levels have been reported in postmarketing experience when cefixime is administered concomitantly. (7.1)
- Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly with warfarin and anticoagulants. (7.2)
7.1 Carbamazepine
7.1 Carbamazepine Elevated carbamazepine levels have been reported in postmarketing experience when cefixime is administered concomitantly. Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations.
7.2 Warfarin and Anticoagulants
7.2 Warfarin and Anticoagulants Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly.
7.3 Drug/Laboratory Test Interactions
7.3 Drug/Laboratory Test Interactions A false-positive reaction for ketones in the urine may occur with tests using nitroprusside but not with those using nitroferricyanide. The administration of cefixime may result in a false positive reaction for glucose in the urine when using glucose tests based on the Benedict's solution or Fehling's solution.
It is recommended that glucose tests based on enzymatic glucose oxidase reactions be used. A false positive direct Coombs test has been reported during treatment with other cephalosporins; therefore, it should be recognized that a positive Coombs test may be due to the drug.
Adverse reactions
Common
- Diarrhea (16%), loose stools (6%)
- Nausea (7%), abdominal pain, dyspepsia, vomiting
Serious
- Anaphylaxis (including shock and death)
- Clostridioides difficile-associated diarrhea
- Fall in prothrombin activity
Most common adverse reactions are gastrointestinal such as diarrhea (16%), nausea (7%), loose stools (6%), abdominal pain (3%), dyspepsia (3%), and vomiting. (6) To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceuticals, Inc. at 1-800-399-2561 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trials Experience
6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The most commonly seen adverse reactions in U.S. trials of the tablet formulation were gastrointestinal events, which were reported in 30% of adult patients on either the twice daily or the once daily regimen.
Five percent (5%) of patients in the U.S. clinical trials discontinued therapy because of drug-related adverse reactions. Individual adverse reactions included diarrhea 16%, loose or frequent stools 6%, abdominal pain 3%, nausea 7%, dyspepsia 3%, and flatulence 4%. The incidence of gastrointestinal adverse reactions, including diarrhea and loose stools, in pediatric patients receiving the suspension was comparable to the incidence seen in adult patients receiving tablets.
6.2 Post-marketing Experience
6.2 Post-marketing Experience The following adverse reactions have been reported following the post-approval use of cefixime. Incidence rates were less than 1 in 50 (less than 2%). Gastrointestinal Several cases of documented pseudomembranous colitis were identified in clinical trials. The onset of pseudomembranous colitis symptoms may occur during or after therapy.
Hypersensitivity Reactions Anaphylactic/anaphylactoid reactions (including shock and fatalities), skin rashes, urticaria, drug fever, pruritus, angioedema, and facial edema. Erythema multiforme, Stevens-Johnson syndrome, and serum sickness-like reactions have been reported. Hepatic Transient elevations in SGPT, SGOT, alkaline phosphatase, hepatitis, jaundice.
Renal Transient elevations in BUN or creatinine, acute renal failure. Central Nervous System Headaches, dizziness, seizures. Hemic and Lymphatic System Transient thrombocytopenia, leukopenia, neutropenia, prolongation in prothrombin time, elevated LDH, pancytopenia, agranulocytosis, and eosinophilia. Abnormal Laboratory Tests Hyperbilirubinemia.
Other Adverse Reactions Genital pruritus, vaginitis, candidiasis, toxic epidermal necrolysis. Adverse Reactions Reported for Cephalosporin-class Drugs Allergic reactions, superinfection, renal dysfunction, toxic nephropathy, hepatic dysfunction including cholestasis, aplastic anemia, hemolytic anemia, hemorrhage, and colitis.
Several cephalosporins have been implicated in triggering seizures, particularly in patients with renal impairment when the dosage was not reduced [s ee Dosage and Administration (2) and Overdosage (10)]. If seizures associated with drug therapy occur, the drug should be discontinued. Anticonvulsant therapy can be given if clinically indicated.
Monitoring parameters
- CrCl for dose; patients on dialysis should be monitored carefully (label 5.3); prothrombin time with warfarin or in patients at risk; diarrhea (CDAD). Kidney
- CrCl for dose
- Prothrombin time when at risk
Pregnancy considerations
Pregnancy (US label) US FDA label
8.1 Pregnancy Risk Summary Available data from published observational studies, case series, and case reports over several decades with cephalosporin use, including cefixime, in pregnant women have not established drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see Data). Reproduction studies have been performed in mice and rats at doses equivalent to 40 and 80 times, respectively, the adult human recommended dose and have revealed no evidence of harm to the fetus due to cefixime (see Data).
The background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.
Clinical Considerations Disease-Associated Maternal and/or Embryo/Fetal Risk Maternal gonorrhea may be associated with preterm birth, low neonatal birth weight, chorioamnionitis, intrauterine growth restriction, small for gestational age and premature rupture of membranes. Perinatal transmission of gonorrhea to the offspring can result in infant blindness, joint infections, and bloodstream infections.
Data Human Data While available studies cannot definitively establish the absence of risk, published data from prospective cohort studies, case series, and case reports over several decades have not identified a consistent association with cephalosporin use, including cefixime, during pregnancy, and major birth defects, miscarriage, or other adverse maternal or fetal outcomes. Available studies have methodological limitations, including small sample size, retrospective data collection, and inconsistent comparator groups.
Animal Data The results of embryo-fetal development studies in mice and rats show that cefixime, at doses up to 3200 mg/kg/day administered during the period of organogenesis did not adversely affect development. In these studies, in mice and rats, cefixime did not affect postnatal development or reproductive capacity of the F 1 generation or fetal development of the F 2 generation.
In an embryo-fetal development study in rabbits, cefixime at doses of 3.2, 10 or 32 mg/kg given daily during the period of organogenesis (gestation days 6 through 18) resulted in abortions and/or maternal deaths at doses > 10 mg/kg (typically associated with the administration of antibiotics in this species), but no malformations were reported at lower doses. A pre- and post-natal development study of cefixime at oral doses up to 3200 mg/kg/day in rats demonstrated no effect on the duration of pregnancy, process of parturition, development and viability of offspring, or reproductive capacity of the F 1 generation and development of their fetuses (F 2).
Mechanism of action
12.1 Mechanism of Action Cefixime is a semisynthetic cephalosporin antibacterial drug [see Microbiology (12.4)].
US FDA labelPharmacokinetics
Key PK parameters
| Half-life | 3 to 4 hours (up to 9 hours in some healthy people) |
|---|---|
| Half-life in kidney failure (ESKD) kidney | About 6.4 hours at CrCl 20–40; 11.5 hours at CrCl 5–20 (label) |
| Protein binding | About 65% |
| Metabolism (CYP, transporters) | No evidence of metabolism |
| Renal excretion kidney | About 50% of the absorbed dose unchanged in urine in 24 hours; over 10% in bile (animal data) |
| Dialyzability kidney | No (label) |
Elimination Metabolism and Excretion There is no evidence of metabolism of cefixime in vivo.
Approximately 50% of the absorbed dose is excreted unchanged in the urine in 24 hours.
In animal studies, it was noted that cefixime is also excreted in the bile in excess of 10% of the administered dose.
The serum half-life of cefixime in healthy subjects is independent of dosage form and averages 3 to 4 hours but may range up to 9 hours in some normal volunteers.
Pharmacokinetic Parameters for Cefixime in Both Young and Elderly Subjects Pharmacokinetic Parameters (mean ± SD) for Cefixime in Both Young & Elderly Subjects Pharmacokinetic parameter Young Elderly C max (mg/L) 4.74 ± 1.43 5.68 ± 1.83 T max (h) * 3.9 ± 0.3 4.3 ± 0.6 AUC (mg.h/L) * 34.9 ± 12.2 49.5 ± 19.1 T ½ (h) * 3.5 ± 0.6 4.2 ± 0.4 C ave (mg/L) * 1.42 ±0.50 1.99 ± 0.75 * Difference between age groups was significant.
Pharmacokinetics (US label) US FDA label
12.3 Pharmacokinetics Cefixime tablets and cefixime for oral suspension, given orally, are about 40% to 50% absorbed whether administered with or without food; however, time to maximal absorption is increased approximately 0.8 hours when administered with food. A single 200 mg tablet of cefixime produces an average peak serum concentration of approximately 2 mcg/mL (range 1 to 4 mcg/mL); a single 400 mg tablet produces an average peak concentration of approximately 3.7 mcg/mL (range 1.3 to 7.7 mcg/mL).
The cefixime oral suspension produces average peak concentrations approximately 25% to 50% higher than the tablets, when tested in normal adult volunteers. Two hundred and 400 mg doses of cefixime oral suspension produce average peak concentrations of 3 mcg/mL (range 1 to 4.5 mcg/mL) and 4.6 mcg/mL (range 1.9 to 7.7 mcg/mL), respectively, when tested in normal adult volunteers.
The area under the time versus concentration curve (AUC) is greater by approximately 10% to 25% with the cefixime for oral suspension than with the tablet after doses of 100 to 400 mg, when tested in normal adult volunteers. This increased absorption should be taken into consideration if the cefixime for oral suspension is to be substituted for the tablet.
Because of the lack of bioequivalence, cefixime tablets should not be substituted for cefixime for oral suspension in the treatment of otitis media [see Dosage and Administration (2)]. Cross-over studies of tablet versus suspension have not been performed in children. The 400 mg cefixime capsule is bioequivalent to the 400 mg cefixime tablet under fasting conditions.
However, food reduces the absorption following administration of the capsule by approximately 15% based on AUC and 25% based on C max. Peak serum concentrations occur between 2 and 6 hours following oral administration of a single 200 mg tablet, a single 400 mg cefixime tablet or 400 mg of cefixime for oral suspension. Peak serum concentrations occur between 2 and 5 hours following a single administration of 200 mg of cefixime for oral suspension.
Peak serum concentrations occur between 3 and 8 hours following oral administration of a single 400 mg cefixime capsule. Distribution Serum protein binding is concentration independent with a bound fraction of approximately 65%. In a multiple dose study conducted with a research formulation which is less bioavailable than the cefixime tablet or cefixime for oral suspension, there was little accumulation of drug in serum or urine after dosing for 14 days.
Adequate data on CSF levels of cefixime are not available. Elimination Metabolism and Excretion There is no evidence of metabolism of cefixime in vivo. Approximately 50% of the absorbed dose is excreted unchanged in the urine in 24 hours. In animal studies, it was noted that cefixime is also excreted in the bile in excess of 10% of the administered dose.
The serum half-life of cefixime in healthy subjects is independent of dosage form and averages 3 to 4 hours but may range up to 9 hours in some normal volunteers. Specific Populations Geriatric Patients: Average AUCs at steady state in elderly patients are approximately 40% higher than average AUCs in other healthy adults.
Differences in the pharmacokinetic parameters between 12 young and 12 elderly subjects who received 400 mg of cefixime once daily for 5 days are summarized as follows: Table 4. Pharmacokinetic Parameters for Cefixime in Both Young and Elderly Subjects Pharmacokinetic Parameters (mean ± SD) for Cefixime in Both Young & Elderly Subjects Pharmacokinetic parameter Young Elderly C max (mg/L) 4.74 ± 1.43 5.68 ± 1.83 T max (h) * 3.9 ± 0.3 4.3 ± 0.6 AUC (mg.h/L) * 34.9 ± 12.2 49.5 ± 19.1 T ½ (h) * 3.5 ± 0.6 4.2 ± 0.4 C ave (mg/L) * 1.42 ±0.50 1.99 ± 0.75 * Difference between age groups was significant.
(p<0.05) However, these increases were not clinically significant [see Dosage and Administration (2)]. Patients with Renal Impairment: In subjects with moderate impairment of renal function (20 to 40 mL/min creatinine clearance), the average serum half-life of cefixime is prolonged to 6.4 hours. In severe renal impairment (5 to 20 mL/min creatinine clearance), the half-life increased to an average of 11.5 hours.
The drug is not cleared significantly from the blood by hemodialysis or peritoneal dialysis. However, a study indicated that with doses of 400 mg of cefixime, patients undergoing hemodialysis have similar blood profiles as subjects with creatinine clearances of 21 to 60 mL/min.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Cefixime 20 mg/mL, 10 mL Suspension | ₱105.00–₱169.00Reference ₱132.31 | per unit | DPRI procurement range |
| Cefixime 100 mg/5 mL, 60 mL Suspension | ₱68.00–₱300.00Reference ₱155.75 | per unit | DPRI procurement range |
| Cefixime 200 mg Capsule | ₱4.40–₱31.00Reference ₱7.74 | per capsule | DPRI procurement range |
| Cefixime 400 mg Capsule | ₱16.20–₱134.00Reference ₱42.50 | per capsule | DPRI procurement range |
| 20 mg/mL granules for suspension (drops) in 10 mL | ₱298.75 | per unit | PhilHealth GAMOT fixed fee |
| 100 mg/5 mL granules for suspension in 60 mL | ₱317.50 | per unit | PhilHealth GAMOT fixed fee |
| 200 mg capsule | ₱63.00 | per capsule | PhilHealth GAMOT fixed fee |
| 400 mg capsule | ₱127.25 | per capsule | PhilHealth GAMOT fixed fee |
PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf, as of October 13, 2026
Formulary and coverage
| Philippine National Formulary | Listed as Cefixime |
| PNF listing | Oral: 200 mg and 400 mg capsuleRestrictions: List B: in vivo bioequivalence studies required (PNF code B) |
| PNF listing | Oral: 20 mg/mL granules for drops (suspension), 10 mL |
| PNF listing | Oral: 100 mg/5 mL granules for suspension, 60 mL |
| PhilHealth GAMOT | Yes (listed since July 28, 2025) |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. CEFIXIME · Lupin Pharmaceuticals, Inc. [US FDA-approved label, version 14, October 14, 2025]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d68dbd9-7d75-4ff1-91db-79ff8ae879ec
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
- Lupin Pharmaceuticals, Inc. (2025). Cefixime capsules and cefixime for oral suspension [Prescribing information; US FDA-approved label, ANDA065129, set ID 6d68dbd9-7d75-4ff1-91db-79ff8ae879ec, version effective October 14, 2025]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d68dbd9-7d75-4ff1-91db-79ff8ae879ec
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.
Last updated: .